201
|
Wu Q, Diao H, Yu M, Liu Q, Ji X, Ge Z, Jin T. Signaling pathway activation changes induced by Cd exposure combined with Cx43 silencing in HK-2. Toxicol Lett 2016. [DOI: 10.1016/j.toxlet.2016.07.390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
202
|
Brower J, Amini A, Hullett C, Wojcieszynski A, Bassetti M, Witek M, Chen S, Yu M, Baschnagel A. Dose-Escalated Radiation Therapy Is Associated With Improved Survival in Patients With Stage III Non-Small Cell Lung Cancer: Analysis of the National Cancer Data Base. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
203
|
Zhao Q, Deng L, Zhang Y, Zhou X, Li Y, Yu M, Zhou L, Zou B, Liu Y, Lu Y. Progression of leptomeningeal metastases in advanced EGFR-mutated non-small cell lung cancer. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw383.42] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
204
|
Chi K, Chowdhury S, Radziszewski P, Lebret T, Ozguroglu M, Sternberg C, Sims R, Yu M, Naini V, Darif M, Merseburger A. TITAN: A randomized, double-blind, placebo-controlled, phase 3 trial of apalutamide (ARN-509) plus androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw372.54] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
205
|
Nazzari H, Hawkins N, Lauck S, Ding L, Polderman J, Yu M, Gerami O, Ezekowitz J, Boone R, Cheung A, Ye J, Wood D, Webb J, Toma M. THE RELATIONSHIP BETWEEN HEART FAILURE READMISSION AND MORTALITY IN PATIENTS RECEIVING TRANSCATHETER AORTIC VALVE IMPLANTATION. Can J Cardiol 2016. [DOI: 10.1016/j.cjca.2016.07.273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
206
|
Bossi A, Dearnaley D, McKenzie M, Baskin-Bey E, Tyler R, Tombal B, Freedland S, Roach M, Widmark A, Dicker A, Wiegel T, Shore N, Smith M, Yu M, Kheoh T, Thomas S, Sandler H. ATLAS: A phase 3 trial evaluating the efficacy of apalutamide (ARN-509) in patients with high-risk localized or locally advanced prostate cancer receiving primary radiation therapy. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw372.52] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
207
|
Ahmed KA, Abuodeh YA, Echevarria MI, Arrington JA, Stallworth DG, Hogue C, Naghavi AO, Kim S, Kim Y, Patel BG, Sarangkasiri S, Johnstone PAS, Sahebjam S, Khushalani NI, Forsyth PA, Harrison LB, Yu M, Etame AB, Caudell JJ. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy. Ann Oncol 2016; 27:2288-2294. [PMID: 27637745 DOI: 10.1093/annonc/mdw417] [Citation(s) in RCA: 102] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2016] [Revised: 06/30/2016] [Accepted: 08/22/2016] [Indexed: 01/23/2023] Open
Abstract
BACKGROUND The effect of immunologic and targeted agents on intracranial response rates in patients with melanoma brain metastases (MBMs) is not yet clearly understood. This report analyzes outcomes of intact MBMs treated with single-session stereotactic radiosurgery (SRS) and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors(i), BRAFi, or conventional chemotherapy. PATIENTS AND METHODS Patients were included if MBMs were treated with single-session SRS within 3 months of receiving systemic therapy. The primary end point of this study was distant MBM control. Secondary end points were local MBM control defined as a >20% volume increase on follow-up MRI, systemic progression-free survival, overall survival (OS) from both SRS and cranial metastases diagnosis, and neurotoxicity. Images were reviewed alongside two neuro-radiologists at our institution. RESULTS Ninety-six patients were treated to 314 MBMs over 119 SRS treatment sessions between January 2007 and August 2015. No significant differences were noted in age (P = 0.27), gender (P = 0.85), treated gross tumor volume (P = 0.26), or the diagnosis-specific graded prognostic assessment (P = 0.51) between the treatment cohorts. Twelve-month Kaplan-Meier (KM) distant MBM control rates were 38%, 21%, 20%, 8%, and 5% (P = 0.008) for SRS with anti-PD-1 therapies, anti-CTLA-4 therapy, BRAF/MEKi, BRAFi, and conventional chemotherapy, respectively. No significant differences were noted in the KM local MBM control rates among treatment groups (P = 0.25). Treatment with anti-PD-1 therapy, anti-CTLA-4 therapy, or BRAF/MEKi significantly improved OS on both univariate and multivariate analyses when compared with conventional chemotherapy. CONCLUSION In our institutional analysis of patients treated with SRS and various systemic immunologic and targeted melanoma agents, significant differences in distant MBM control and OS are noted. Prospective evaluation of the potential synergistic effect between these agents and SRS is warranted.
Collapse
Affiliation(s)
| | | | | | - J A Arrington
- Department of Radiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa
| | - D G Stallworth
- Department of Radiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa
| | - C Hogue
- Department of School of Medicine, University of Louisville, Louisville
| | | | - S Kim
- Department of Radiation Oncology
| | - Y Kim
- Department of Biostatistics, H. Lee Moffitt Cancer Center and Research Institute, Tampa
| | - B G Patel
- Department of Morsani College of Medicine, University of South Florida, Tampa
| | | | | | - S Sahebjam
- Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa
| | - N I Khushalani
- Department of Cutaneous-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA
| | - P A Forsyth
- Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa
| | | | - M Yu
- Department of Radiation Oncology
| | - A B Etame
- Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa
| | | |
Collapse
|
208
|
Andre H, Mammadzada P, Tunik S, Takei A, Ekström M, Yu M, Aronsson M, Kvanta A. Gene transfer of prolyl hydroxylase domain 2 inhibits hypoxia-inducible angiogenesis in a model of choroidal neovascularization. Acta Ophthalmol 2016. [DOI: 10.1111/j.1755-3768.2016.0278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
209
|
Zhang L, Sun Y, Jiang C, Zuo L, Shen H, Hu G, Wang Y, Chen A, Wu F, Yu M, Diao Y, Liu N. Dorsal open reduction with pedicle screw rod internal fixation for lower cervical spine dislocation: A retrospective analysis of 12 cases. Neurochirurgie 2016; 62:245-250. [PMID: 27591032 DOI: 10.1016/j.neuchi.2016.03.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2015] [Revised: 12/15/2015] [Accepted: 03/20/2016] [Indexed: 12/29/2022]
Abstract
BACKGROUND Lower cervical spine dislocation remains a surgical challenge. METHODS Twelve patients with lower cervical dislocation due to articular process injury underwent dorsal open reduction and manual pedicle screw rod fixation. Patients with cervical spinal cord injury received simultaneous open door expansive laminoplasty. Neurological function was evaluated using ASIA Impairment Scale 12. RESULTS Median time from injury to operation was 10 days (range, 5 to 52 days). Anatomic reduction was achieved in all patients. In nine patients with cervical spinal cord injury, 55.5% (5/9) showed improvement in ASIA grade following surgery. Unilateral numbness of the superior radicular area in one patient resolved 2 weeks post-surgery and two cases (11.1%, 2/9) had postoperative leakage of the cerebrospinal fluid, which resolved in 11 days and 13 days, respectively. CONCLUSION Dorsal open reduction and manual pedicle screw rod fixation is safe and effective for lower cervical spine dislocation due to articular process injury.
Collapse
Affiliation(s)
- L Zhang
- Department of orthopedic surgery, Peking university Third Hospital, 100191 Beijing, China
| | - Y Sun
- Department of orthopedic surgery, Peking university Third Hospital, 100191 Beijing, China.
| | - C Jiang
- Department of orthopedic surgery, The Armed Police General Hospital, 100039 Beijing, China
| | - L Zuo
- Department of orthopedic surgery, Henan Anyang People's Hospital, 455000 Anyang, Henan, China
| | - H Shen
- Department of orthopedic surgery, Beijing Shuyi Hospital of China medical university, 101300 Beijing, China
| | - G Hu
- Department of orthopedic surgery, Liaoning Chaoyang Central Hospital, 122000 Chaoyang, Liaoning, China
| | - Y Wang
- Department of surgery, Beijing North Hospital of Ordnance Industry, 100081 Beijing, China
| | - A Chen
- Department of surgery, Beijing North Hospital of Ordnance Industry, 100081 Beijing, China
| | - F Wu
- Department of orthopedic surgery, Peking university Third Hospital, 100191 Beijing, China
| | - M Yu
- Department of orthopedic surgery, Peking university Third Hospital, 100191 Beijing, China
| | - Y Diao
- Department of orthopedic surgery, Peking university Third Hospital, 100191 Beijing, China
| | - N Liu
- Department of orthopedic surgery, Peking university Third Hospital, 100191 Beijing, China
| |
Collapse
|
210
|
Sterbing-D'Angelo SJ, Liu H, Yu M, Moss CF. Morphology and deflection properties of bat wing sensory hairs: scanning electron microscopy, laser scanning vibrometry, and mechanics model. Bioinspir Biomim 2016; 11:056008. [PMID: 27545727 DOI: 10.1088/1748-3190/11/5/056008] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Bat wings are highly adaptive airfoils that enable demanding flight maneuvers, which are performed with astonishing robustness under turbulent conditions, and stability at slow flight velocities. The bat wing is sparsely covered with microscopically small, sensory hairs that are associated with tactile receptors. In a previous study we demonstrated that bat wing hairs are involved in sensing airflow for improved flight maneuverability. Here, we report physical measurements of these hairs and their distribution on the wing surface of the big brown bat, Eptesicus fuscus, based on scanning electron microscopy analyses. The wing hairs are strongly tapered, and are found on both the dorsal and ventral wing surfaces. Laser scanning vibrometry tests of 43 hairs from twelve locations across the wing of the big brown bat revealed that their natural frequencies inversely correlate with length and range from 3.7 to 84.5 kHz. Young's modulus of the average wing hair was calculated at 4.4 GPa, which is comparable with rat whiskers or arthropod airflow-sensing hairs.
Collapse
|
211
|
Jie H, Li PM, Zhao GJ, Feng XL, Zeng DJ, Zhang CL, Lei MY, Yu M, Chen Q. Amino acid composition of royal jelly harvested at different times after larval transfer. Genet Mol Res 2016; 15:gmr8306. [PMID: 27525943 DOI: 10.4238/gmr.15038306] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The amino acids in royal jelly (RJ) have a wide range of pharmacological and health-promoting functions in humans. Multiple studies on the amino acid quality and composition in RJ have investigated RJ harvested at 72 h after larval transfer. In contrast, the concentration of amino acids in RJ harvested before 72 h remains unknown. In this study, the concentration of free amino acids (FAAs) and total amino acids (TAAs) in RJ harvested at 13 time points between 24 and 72 h after transfer of ten Apis mellifera colonies were measured. Our results indicated that the most abundant FAAs were Pro, Phe, Lys, Glu, and Tyr, whereas the most abundant TAAs were Asp, Glu, Leu, Lys, and Val. The total FAA concentration in RJ increased with increasing harvest time, from 4.30 mg/g at 24 h to 9.48 mg/g at 72 h. In contrast, the variation in concentration of TAAs observed was a decrease-increase-decrease trend with 40 h (149.53 mg/g) and 52 h (169.62 mg/g) as inflection points. The highest and lowest concentrations of TAA were 197.96 and 121.32 mg/g at 24 and 72 h, respectively. To our knowledge, this is the first study to investigate the concentration changes of FAAs and TAAs prior to 72 h after transfer. Our results will provide theoretical support to guide production practices of beekeeping, as well as elucidate the relationship between the harvest time point and RJ content.
Collapse
Affiliation(s)
- H Jie
- Laboratory of Medicinal Animal, Chongqing Institute of Medicinal Plant Cultivation, Chongqing, China
| | - P M Li
- Laboratory of Medicinal Animal, Chongqing Institute of Medicinal Plant Cultivation, Chongqing, China
| | - G J Zhao
- Laboratory of Medicinal Animal, Chongqing Institute of Medicinal Plant Cultivation, Chongqing, China
| | - X L Feng
- Laboratory of Medicinal Animal, Chongqing Institute of Medicinal Plant Cultivation, Chongqing, China
| | - D J Zeng
- Laboratory of Medicinal Animal, Chongqing Institute of Medicinal Plant Cultivation, Chongqing, China
| | - C L Zhang
- Laboratory of Medicinal Animal, Chongqing Institute of Medicinal Plant Cultivation, Chongqing, China
| | - M Y Lei
- Laboratory of Medicinal Animal, Chongqing Institute of Medicinal Plant Cultivation, Chongqing, China
| | - M Yu
- Laboratory of Medicinal Animal, Chongqing Institute of Medicinal Plant Cultivation, Chongqing, China
| | - Q Chen
- Laboratory of Medicinal Animal, Chongqing Institute of Medicinal Plant Cultivation, Chongqing, China
| |
Collapse
|
212
|
Brower JV, Amini A, Chen S, Hullett CR, Kimple RJ, Wojcieszynski AP, Bassetti M, Witek ME, Yu M, Harari PM, Baschnagel AM. Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database. Ann Oncol 2016; 27:1887-94. [PMID: 27502703 DOI: 10.1093/annonc/mdw276] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2016] [Accepted: 07/02/2016] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Concurrent chemoradiation is the standard of care in non-operable stage III non-small-cell lung cancer (NSCLC). Data have suggested a benefit of dose escalation; however, results from the randomized dose-escalation trial RTOG 0617 revealed a lower survival rate with high-dose radiation. To evaluate the impact of dose escalation on overall survival (OS) in stage III NSCLC treated with chemoradiotherapy outside the controlled setting of a randomized trial, we carried out an observational, population-based investigation of the National Cancer Database (NCDB). PATIENTS AND METHODS A total of 33 566 patients with stage III NSCLC treated with chemoradiation from 2004 to 2012 and radiation doses between 59.4 and 85 Gy were included. The primary end point was OS, with median survival calculated via Kaplan-Meier. Univariate, multivariable and propensity-score matching analyses were carried out. RESULTS Patients were stratified by dose with median OS of: 18.8, 19.8 and 21.6 months for cohorts receiving 59.4-60, 61-69 and ≥70 Gy, respectively (P < 0.001). Granular dose analyses were carried out demonstrating increased OS with increasing radiation dose: median survival of 18.8, 21.1, 22.0 and 21.0 months for 59.4-60, 66, 70 and ≥71 Gy, respectively. While 66, 70 and ≥71 Gy resulted in increased OS in comparison with 59.4-60 Gy, no significant difference in OS was observed when comparing 66 with ≥71 Gy (P = 0.38). CONCLUSIONS Dose escalation above 60 Gy was associated with improved OS in this cohort of stage III NSCLC patients treated with chemoradiotherapy. A plateau of benefit was observed, with no additional improvement in OS with increased dose (≥71 Gy) compared with 66-70 Gy. With evidence suggesting worse OS and quality of life with increased dose, these data support investigation of the role of intermediate-dose radiation, and in the absence of randomized evidence, may be leveraged to justify utilization of intermediate-dose radiation.
Collapse
Affiliation(s)
- J V Brower
- Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison
| | - A Amini
- Department of Radiation Oncology, University of Colorado, Anschutz Medical Campus, Aurora
| | - S Chen
- Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, USA
| | - C R Hullett
- Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison
| | - R J Kimple
- Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison
| | - A P Wojcieszynski
- Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison
| | - M Bassetti
- Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison
| | - M E Witek
- Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison
| | - M Yu
- Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, USA
| | - P M Harari
- Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison
| | - A M Baschnagel
- Department of Human Oncology, University of Wisconsin Hospital and Clinics, Madison
| |
Collapse
|
213
|
Boustani MA, Pittman I, Yu M, Thieu VT, Varnado OJ, Juneja R. Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years. Diabetes Obes Metab 2016; 18:820-8. [PMID: 27161178 PMCID: PMC5089646 DOI: 10.1111/dom.12687] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/15/2016] [Revised: 02/25/2016] [Accepted: 04/29/2016] [Indexed: 01/12/2023]
Abstract
AIMS To evaluate the efficacy and safety of dulaglutide 1.5 and 0.75 mg in elderly patients (aged ≥65 years) with type 2 diabetes (T2D) in six phase III clinical trials. METHODS Patients were grouped into two age groups: ≥65 and <65 years. Pooled analysis for glycated haemoglobin (HbA1c) change from baseline, percentage of patients achieving HbA1c targets, and gastrointestinal tolerability were evaluated at 26 weeks for each dulaglutide dose. Change in weight from baseline and rates of hypoglycaemia were evaluated for each individual study. RESULTS A total of 958 of 5171 (18.5%) patients were aged ≥65 years. The reductions in HbA1c were similar between age groups for dulaglutide 1.5 mg-treated patients {least squares [LS] mean for patients aged ≥65 years: -1.24 [95% confidence interval (CI) -1.36, -1.12] and for patients aged <65 years: -1.29 [95% CI -1.38, -1.20]} and for dulaglutide 0.75 mg-treated patients [LS mean for patients aged ≥65 years: -1.16 (95% CI -1.29, -1.03) and for patients aged <65 years: -1.10 (95% CI -1.19, -1.01)] at 26 weeks. The percentages of patients who achieved HbA1c targets of <7, <8 or <9% were also similar in the two groups with both dulaglutide doses. Patients aged ≥65 years had similar weight change to patients aged <65 years. Severe hypoglycaemic events were infrequent. A similar incidence of gastrointestinal adverse events was observed in each age group with both dulaglutide doses. CONCLUSION Both dulaglutide doses were well tolerated, with similar efficacy in patients with T2D aged ≥65 years to those aged <65 years. Dulaglutide can be considered a safe and effective treatment option for use in older adults.
Collapse
Affiliation(s)
| | - I Pittman
- Providence Medical Group, Terre Haute, IN, USA
| | - M Yu
- Eli Lilly and Company, Toronto, ON, Canada
| | - V T Thieu
- Eli Lilly and Company, Indianapolis, IN, USA
| | - O J Varnado
- Eli Lilly and Company, Indianapolis, IN, USA
| | - R Juneja
- Eli Lilly and Company, Indianapolis, IN, USA
| |
Collapse
|
214
|
Nakamura M, Sugimoto H, Ogata T, Hiraoka K, Yoda H, Sang M, Sang M, Zhu Y, Yu M, Shimozato O, Ozaki T. Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death. Oncogenesis 2016; 5:e233. [PMID: 27294865 PMCID: PMC4945741 DOI: 10.1038/oncsis.2016.40] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2015] [Revised: 04/21/2016] [Accepted: 05/03/2016] [Indexed: 12/12/2022] Open
Abstract
Pancreatic cancer exhibits the worst prognostic outcome among human cancers. Recently, we have described that depletion of RUNX2 enhances gemcitabine (GEM) sensitivity of p53-deficient pancreatic cancer AsPC-1 cells through the activation of TAp63-mediated cell death pathway. These findings raised a question whether RUNX2 silencing could also improve GEM efficacy on pancreatic cancer cells bearing p53 mutation. In the present study, we have extended our study to p53-mutated pancreatic cancer MiaPaCa-2 cells. Based on our current results, MiaPaCa-2 cells were much more resistant to GEM as compared with p53-proficient pancreatic cancer SW1990 cells, and there existed a clear inverse relationship between the expression levels of TAp73 and RUNX2 in response to GEM. Forced expression of TAp73α in MiaPaCa-2 cells significantly promoted cell cycle arrest and/or cell death, indicating that a large amount of TAp73 might induce cell death even in the presence of mutant p53. Consistent with this notion, overexpression of TAp73α stimulated luciferase activity driven by p53/TAp73-target gene promoters in MiaPaCa-2 cells. Similar to AsPC-1 cells, small interfering RNA-mediated knockdown of RUNX2 remarkably enhanced GEM sensitivity of MiPaCa-2 cells. Under our experimental conditions, TAp73 further accumulated in RUNX2-depleted MiaPaCa-2 cells exposed to GEM relative to GEM-treated non-silencing control cells. As expected, silencing of p73 reduced GEM sensitivity of MiPaCa-2 cells. Moreover, GEM-mediated Tyr phosphorylation level of TAp73 was much more elevated in RUNX2-depleted MiaPaCa-2 cells. Collectively, our present findings strongly suggest that knockdown of RUNX2 contributes to a prominent enhancement of GEM sensitivity of p53-mutated pancreatic cancer cells through the activation of TAp73-mediated cell death pathway, and also provides a promising strategy for the treatment of patients with pancreatic cancer bearing p53 mutation.
Collapse
Affiliation(s)
- M Nakamura
- Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Chiba, Japan
| | - H Sugimoto
- Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Chiba, Japan
| | - T Ogata
- Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Chiba, Japan
| | - K Hiraoka
- Laboratory of Cancer Genetics, Chiba Cancer Center Research Institute, Chiba, Japan
| | - H Yoda
- Laboratory of Cancer Genetics, Chiba Cancer Center Research Institute, Chiba, Japan
| | - M Sang
- Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Chiba, Japan.,Department of Regenerative Medicine, Graduate School of Medicine, University of Toyama, Toyama, Japan
| | - M Sang
- Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Chiba, Japan.,Research Center, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei province, P.R. China
| | - Y Zhu
- Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Chiba, Japan.,Department of Urology, First Hospital of China Medical University, Shenyang, Liaoning Sheng province, P.R. China
| | - M Yu
- Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Chiba, Japan.,Department of Laboratory Animal of China Medical University, Shenyang, Liaoning Sheng province, P.R. China
| | - O Shimozato
- Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Chiba, Japan
| | - T Ozaki
- Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Chiba, Japan
| |
Collapse
|
215
|
Abe K, Andreopoulos C, Antonova M, Aoki S, Ariga A, Assylbekov S, Autiero D, Barbi M, Barker GJ, Barr G, Bartet-Friburg P, Batkiewicz M, Bay F, Berardi V, Berkman S, Bhadra S, Blondel A, Bolognesi S, Bordoni S, Boyd SB, Brailsford D, Bravar A, Bronner C, Buizza Avanzini M, Calland RG, Cao S, Caravaca Rodríguez J, Cartwright SL, Castillo R, Catanesi MG, Cervera A, Cherdack D, Chikuma N, Christodoulou G, Clifton A, Coleman J, Collazuol G, Cremonesi L, Dabrowska A, De Rosa G, Dealtry T, Denner PF, Dennis SR, Densham C, Dewhurst D, Di Lodovico F, Di Luise S, Dolan S, Drapier O, Duffy KE, Dumarchez J, Dytman S, Dziewiecki M, Emery-Schrenk S, Ereditato A, Feusels T, Finch AJ, Fiorentini GA, Friend M, Fujii Y, Fukuda D, Fukuda Y, Furmanski AP, Galymov V, Garcia A, Giffin SG, Giganti C, Gizzarelli F, Gonin M, Grant N, Hadley DR, Haegel L, Haigh MD, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings NC, Hayashino T, Hayato Y, Helmer RL, Hierholzer M, Hillairet A, Himmel A, Hiraki T, Hirota S, Hogan M, Holeczek J, Horikawa S, Hosomi F, Huang K, Ichikawa AK, Ieki K, Ikeda M, Imber J, Insler J, Intonti RA, Irvine TJ, Ishida T, Ishii T, Iwai E, Iwamoto K, Izmaylov A, Jacob A, Jamieson B, Jiang M, Johnson S, Jo JH, Jonsson P, Jung CK, Kabirnezhad M, Kaboth AC, Kajita T, Kakuno H, Kameda J, Karlen D, Karpikov I, Katori T, Kearns E, Khabibullin M, Khotjantsev A, Kielczewska D, Kikawa T, Kim H, Kim J, King S, Kisiel J, Knight A, Knox A, Kobayashi T, Koch L, Koga T, Konaka A, Kondo K, Kopylov A, Kormos LL, Korzenev A, Koshio Y, Kropp W, Kudenko Y, Kurjata R, Kutter T, Lagoda J, Lamont I, Larkin E, Laveder M, Lawe M, Lazos M, Lindner T, Liptak ZJ, Litchfield RP, Li X, Longhin A, Lopez JP, Ludovici L, Lu X, Magaletti L, Mahn K, Malek M, Manly S, Marino AD, Marteau J, Martin JF, Martins P, Martynenko S, Maruyama T, Matveev V, Mavrokoridis K, Ma WY, Mazzucato E, McCarthy M, McCauley N, McFarland KS, McGrew C, Mefodiev A, Mezzetto M, Mijakowski P, Minamino A, Mineev O, Mine S, Missert A, Miura M, Moriyama S, Mueller TA, Murphy S, Myslik J, Nakadaira T, Nakahata M, Nakamura KG, Nakamura K, Nakamura KD, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, Nowak J, O'Keeffe HM, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser SM, Ovsyannikova T, Owen RA, Oyama Y, Palladino V, Palomino JL, Paolone V, Patel ND, Pavin M, Payne D, Perkin JD, Petrov Y, Pickard L, Pickering L, Pinzon Guerra ES, Pistillo C, Popov B, Posiadala-Zezula M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff PN, Ravonel M, Rayner MAM, Redij A, Reinherz-Aronis E, Riccio C, Rojas P, Rondio E, Roth S, Rubbia A, Rychter A, Sacco R, Sakashita K, Sánchez F, Sato F, Scantamburlo E, Scholberg K, Schoppmann S, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaikhiev A, Shaker F, Shaw D, Shiozawa M, Shirahige T, Short S, Smy M, Sobczyk JT, Sorel M, Southwell L, Stamoulis P, Steinmann J, Stewart T, Suda Y, Suvorov S, Suzuki A, Suzuki K, Suzuki SY, Suzuki Y, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka HK, Tanaka HA, Terhorst D, Terri R, Thakore T, Thompson LF, Tobayama S, Toki W, Tomura T, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Vacheret A, Vagins M, Vallari Z, Vasseur G, Wachala T, Wakamatsu K, Walter CW, Wark D, Warzycha W, Wascko MO, Weber A, Wendell R, Wilkes RJ, Wilking MJ, Wilkinson C, Wilson JR, Wilson RJ, Yamada Y, Yamamoto K, Yamamoto M, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yoo J, Yoshida K, Yuan T, Yu M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Żmuda J. Measurement of Muon Antineutrino Oscillations with an Accelerator-Produced Off-Axis Beam. Phys Rev Lett 2016; 116:181801. [PMID: 27203315 DOI: 10.1103/physrevlett.116.181801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/08/2015] [Indexed: 06/05/2023]
Abstract
T2K reports its first measurements of the parameters governing the disappearance of ν[over ¯]_{μ} in an off-axis beam due to flavor change induced by neutrino oscillations. The quasimonochromatic ν[over ¯]_{μ} beam, produced with a peak energy of 0.6 GeV at J-PARC, is observed at the far detector Super-Kamiokande, 295 km away, where the ν[over ¯]_{μ} survival probability is expected to be minimal. Using a data set corresponding to 4.01×10^{20} protons on target, 34 fully contained μ-like events were observed. The best-fit oscillation parameters are sin^{2}(θ[over ¯]_{23})=0.45 and |Δm[over ¯]_{32}^{2}|=2.51×10^{-3} eV^{2} with 68% confidence intervals of 0.38-0.64 and 2.26-2.80×10^{-3} eV^{2}, respectively. These results are in agreement with existing antineutrino parameter measurements and also with the ν_{μ} disappearance parameters measured by T2K.
Collapse
Affiliation(s)
- K Abe
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - C Andreopoulos
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - M Antonova
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - S Aoki
- Kobe University, Kobe, Japan
| | - A Ariga
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - S Assylbekov
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - D Autiero
- Université de Lyon, Université Claude Bernard Lyon 1, IPN Lyon (IN2P3), Villeurbanne, France
| | - M Barbi
- University of Regina, Department of Physics, Regina, Saskatchewan, Canada
| | - G J Barker
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - G Barr
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - P Bartet-Friburg
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | - M Batkiewicz
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - F Bay
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - V Berardi
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - S Berkman
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - S Bhadra
- York University, Department of Physics and Astronomy, Toronto, Ontario, Canada
| | - A Blondel
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | | | - S Bordoni
- Institut de Fisica d'Altes Energies (IFAE), Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - S B Boyd
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - D Brailsford
- Imperial College London, Department of Physics, London, United Kingdom
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - A Bravar
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - C Bronner
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - M Buizza Avanzini
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - R G Calland
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - S Cao
- Kyoto University, Department of Physics, Kyoto, Japan
| | - J Caravaca Rodríguez
- Institut de Fisica d'Altes Energies (IFAE), Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - S L Cartwright
- University of Sheffield, Department of Physics and Astronomy, Sheffield, United Kingdom
| | - R Castillo
- Institut de Fisica d'Altes Energies (IFAE), Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - M G Catanesi
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - A Cervera
- IFIC (CSIC and University of Valencia), Valencia, Spain
| | - D Cherdack
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - N Chikuma
- University of Tokyo, Department of Physics, Tokyo, Japan
| | - G Christodoulou
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - A Clifton
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - J Coleman
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - G Collazuol
- INFN Sezione di Padova and Università di Padova, Dipartimento di Fisica, Padova, Italy
| | - L Cremonesi
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - A Dabrowska
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - G De Rosa
- INFN Sezione di Napoli and Università di Napoli, Dipartimento di Fisica, Napoli, Italy
| | - T Dealtry
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - P F Denner
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - S R Dennis
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - C Densham
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - D Dewhurst
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - F Di Lodovico
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - S Di Luise
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - S Dolan
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - O Drapier
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - K E Duffy
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - J Dumarchez
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | - S Dytman
- University of Pittsburgh, Department of Physics and Astronomy, Pittsburgh, Pennsylvania, USA
| | - M Dziewiecki
- Warsaw University of Technology, Institute of Radioelectronics, Warsaw, Poland
| | | | - A Ereditato
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - T Feusels
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - A J Finch
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - G A Fiorentini
- York University, Department of Physics and Astronomy, Toronto, Ontario, Canada
| | - M Friend
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Fujii
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - D Fukuda
- Okayama University, Department of Physics, Okayama, Japan
| | - Y Fukuda
- Miyagi University of Education, Department of Physics, Sendai, Japan
| | - A P Furmanski
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - V Galymov
- Université de Lyon, Université Claude Bernard Lyon 1, IPN Lyon (IN2P3), Villeurbanne, France
| | - A Garcia
- Institut de Fisica d'Altes Energies (IFAE), Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - S G Giffin
- University of Regina, Department of Physics, Regina, Saskatchewan, Canada
| | - C Giganti
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | | | - M Gonin
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - N Grant
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - D R Hadley
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - L Haegel
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - M D Haigh
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - P Hamilton
- Imperial College London, Department of Physics, London, United Kingdom
| | - D Hansen
- University of Pittsburgh, Department of Physics and Astronomy, Pittsburgh, Pennsylvania, USA
| | - T Hara
- Kobe University, Kobe, Japan
| | - M Hartz
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- TRIUMF, Vancouver, British Columbia, Canada
| | - T Hasegawa
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - N C Hastings
- University of Regina, Department of Physics, Regina, Saskatchewan, Canada
| | - T Hayashino
- Kyoto University, Department of Physics, Kyoto, Japan
| | - Y Hayato
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - R L Helmer
- TRIUMF, Vancouver, British Columbia, Canada
| | - M Hierholzer
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - A Hillairet
- University of Victoria, Department of Physics and Astronomy, Victoria, British Columbia, Canada
| | - A Himmel
- Duke University, Department of Physics, Durham, North Carolina, USA
| | - T Hiraki
- Kyoto University, Department of Physics, Kyoto, Japan
| | - S Hirota
- Kyoto University, Department of Physics, Kyoto, Japan
| | - M Hogan
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - J Holeczek
- University of Silesia, Institute of Physics, Katowice, Poland
| | - S Horikawa
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - F Hosomi
- University of Tokyo, Department of Physics, Tokyo, Japan
| | - K Huang
- Kyoto University, Department of Physics, Kyoto, Japan
| | - A K Ichikawa
- Kyoto University, Department of Physics, Kyoto, Japan
| | - K Ieki
- Kyoto University, Department of Physics, Kyoto, Japan
| | - M Ikeda
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - J Imber
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - J Insler
- Louisiana State University, Department of Physics and Astronomy, Baton Rouge, Louisiana, USA
| | - R A Intonti
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - T J Irvine
- University of Tokyo, Institute for Cosmic Ray Research, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - T Ishida
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - T Ishii
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - E Iwai
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Iwamoto
- University of Rochester, Department of Physics and Astronomy, Rochester, New York, USA
| | - A Izmaylov
- IFIC (CSIC and University of Valencia), Valencia, Spain
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - A Jacob
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - B Jamieson
- University of Winnipeg, Department of Physics, Winnipeg, Manitoba, Canada
| | - M Jiang
- Kyoto University, Department of Physics, Kyoto, Japan
| | - S Johnson
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - J H Jo
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - P Jonsson
- Imperial College London, Department of Physics, London, United Kingdom
| | - C K Jung
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - M Kabirnezhad
- National Centre for Nuclear Research, Warsaw, Poland
| | - A C Kaboth
- Royal Holloway University of London, Department of Physics, Egham, Surrey, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - T Kajita
- University of Tokyo, Institute for Cosmic Ray Research, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - H Kakuno
- Tokyo Metropolitan University, Department of Physics, Tokyo, Japan
| | - J Kameda
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - D Karlen
- TRIUMF, Vancouver, British Columbia, Canada
- University of Victoria, Department of Physics and Astronomy, Victoria, British Columbia, Canada
| | - I Karpikov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - T Katori
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - E Kearns
- Boston University, Department of Physics, Boston, Massachusetts, USA
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - M Khabibullin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - A Khotjantsev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - D Kielczewska
- University of Warsaw, Faculty of Physics, Warsaw, Poland
| | - T Kikawa
- Kyoto University, Department of Physics, Kyoto, Japan
| | - H Kim
- Osaka City University, Department of Physics, Osaka, Japan
| | - J Kim
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - S King
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - J Kisiel
- University of Silesia, Institute of Physics, Katowice, Poland
| | - A Knight
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - A Knox
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - T Kobayashi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - L Koch
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - T Koga
- University of Tokyo, Department of Physics, Tokyo, Japan
| | - A Konaka
- TRIUMF, Vancouver, British Columbia, Canada
| | - K Kondo
- Kyoto University, Department of Physics, Kyoto, Japan
| | - A Kopylov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - L L Kormos
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - A Korzenev
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - Y Koshio
- Okayama University, Department of Physics, Okayama, Japan
| | - W Kropp
- University of California, Irvine, Department of Physics and Astronomy, Irvine, California, USA
| | - Y Kudenko
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - R Kurjata
- Warsaw University of Technology, Institute of Radioelectronics, Warsaw, Poland
| | - T Kutter
- Louisiana State University, Department of Physics and Astronomy, Baton Rouge, Louisiana, USA
| | - J Lagoda
- National Centre for Nuclear Research, Warsaw, Poland
| | - I Lamont
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - E Larkin
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - M Laveder
- INFN Sezione di Padova and Università di Padova, Dipartimento di Fisica, Padova, Italy
| | - M Lawe
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - M Lazos
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - T Lindner
- TRIUMF, Vancouver, British Columbia, Canada
| | - Z J Liptak
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - R P Litchfield
- University of Warwick, Department of Physics, Coventry, United Kingdom
| | - X Li
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - A Longhin
- INFN Sezione di Padova and Università di Padova, Dipartimento di Fisica, Padova, Italy
| | - J P Lopez
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - L Ludovici
- INFN Sezione di Roma and Università di Roma "La Sapienza," Roma, Italy
| | - X Lu
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - L Magaletti
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - K Mahn
- Michigan State University, Department of Physics and Astronomy, East Lansing, Michigan, USA
| | - M Malek
- University of Sheffield, Department of Physics and Astronomy, Sheffield, United Kingdom
| | - S Manly
- University of Rochester, Department of Physics and Astronomy, Rochester, New York, USA
| | - A D Marino
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - J Marteau
- Université de Lyon, Université Claude Bernard Lyon 1, IPN Lyon (IN2P3), Villeurbanne, France
| | - J F Martin
- University of Toronto, Department of Physics, Toronto, Ontario, Canada
| | - P Martins
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - S Martynenko
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - T Maruyama
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - V Matveev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - K Mavrokoridis
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - W Y Ma
- Imperial College London, Department of Physics, London, United Kingdom
| | | | - M McCarthy
- York University, Department of Physics and Astronomy, Toronto, Ontario, Canada
| | - N McCauley
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - K S McFarland
- University of Rochester, Department of Physics and Astronomy, Rochester, New York, USA
| | - C McGrew
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - A Mefodiev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - M Mezzetto
- INFN Sezione di Padova and Università di Padova, Dipartimento di Fisica, Padova, Italy
| | - P Mijakowski
- National Centre for Nuclear Research, Warsaw, Poland
| | - A Minamino
- Kyoto University, Department of Physics, Kyoto, Japan
| | - O Mineev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - S Mine
- University of California, Irvine, Department of Physics and Astronomy, Irvine, California, USA
| | - A Missert
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - M Miura
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - S Moriyama
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - Th A Mueller
- Ecole Polytechnique, IN2P3-CNRS, Laboratoire Leprince-Ringuet, Palaiseau, France
| | - S Murphy
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - J Myslik
- University of Victoria, Department of Physics and Astronomy, Victoria, British Columbia, Canada
| | - T Nakadaira
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - M Nakahata
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - K G Nakamura
- Kyoto University, Department of Physics, Kyoto, Japan
| | - K Nakamura
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - K D Nakamura
- Kyoto University, Department of Physics, Kyoto, Japan
| | - S Nakayama
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - T Nakaya
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- Kyoto University, Department of Physics, Kyoto, Japan
| | - K Nakayoshi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - C Nantais
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - C Nielsen
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - M Nirkko
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - K Nishikawa
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Nishimura
- University of Tokyo, Institute for Cosmic Ray Research, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - J Nowak
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - H M O'Keeffe
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - R Ohta
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Okumura
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- University of Tokyo, Institute for Cosmic Ray Research, Research Center for Cosmic Neutrinos, Kashiwa, Japan
| | - T Okusawa
- Osaka City University, Department of Physics, Osaka, Japan
| | - W Oryszczak
- University of Warsaw, Faculty of Physics, Warsaw, Poland
| | - S M Oser
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - T Ovsyannikova
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - R A Owen
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - Y Oyama
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - V Palladino
- INFN Sezione di Napoli and Università di Napoli, Dipartimento di Fisica, Napoli, Italy
| | - J L Palomino
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - V Paolone
- University of Pittsburgh, Department of Physics and Astronomy, Pittsburgh, Pennsylvania, USA
| | - N D Patel
- Kyoto University, Department of Physics, Kyoto, Japan
| | - M Pavin
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | - D Payne
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - J D Perkin
- University of Sheffield, Department of Physics and Astronomy, Sheffield, United Kingdom
| | - Y Petrov
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - L Pickard
- University of Sheffield, Department of Physics and Astronomy, Sheffield, United Kingdom
| | - L Pickering
- Imperial College London, Department of Physics, London, United Kingdom
| | - E S Pinzon Guerra
- York University, Department of Physics and Astronomy, Toronto, Ontario, Canada
| | - C Pistillo
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - B Popov
- UPMC, Université Paris Diderot, CNRS/IN2P3, Laboratoire de Physique Nucléaire et de Hautes Energies (LPNHE), Paris, France
| | | | | | | | - P Przewlocki
- National Centre for Nuclear Research, Warsaw, Poland
| | - B Quilain
- Kyoto University, Department of Physics, Kyoto, Japan
| | - E Radicioni
- INFN Sezione di Bari and Università e Politecnico di Bari, Dipartimento Interuniversitario di Fisica, Bari, Italy
| | - P N Ratoff
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - M Ravonel
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - M A M Rayner
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - A Redij
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - E Reinherz-Aronis
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - C Riccio
- INFN Sezione di Napoli and Università di Napoli, Dipartimento di Fisica, Napoli, Italy
| | - P Rojas
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - E Rondio
- National Centre for Nuclear Research, Warsaw, Poland
| | - S Roth
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - A Rubbia
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - A Rychter
- Warsaw University of Technology, Institute of Radioelectronics, Warsaw, Poland
| | - R Sacco
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - K Sakashita
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - F Sánchez
- Institut de Fisica d'Altes Energies (IFAE), Barcelona Institute of Science and Technology, Campus UAB, Bellaterra (Barcelona), Spain
| | - F Sato
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - E Scantamburlo
- University of Geneva, Section de Physique, DPNC, Geneva, Switzerland
| | - K Scholberg
- Duke University, Department of Physics, Durham, North Carolina, USA
| | - S Schoppmann
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - J Schwehr
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - M Scott
- TRIUMF, Vancouver, British Columbia, Canada
| | - Y Seiya
- Osaka City University, Department of Physics, Osaka, Japan
| | - T Sekiguchi
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - H Sekiya
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - D Sgalaberna
- ETH Zurich, Institute for Particle Physics, Zurich, Switzerland
| | - R Shah
- Oxford University, Department of Physics, Oxford, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - A Shaikhiev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - F Shaker
- University of Winnipeg, Department of Physics, Winnipeg, Manitoba, Canada
| | - D Shaw
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - M Shiozawa
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - T Shirahige
- Okayama University, Department of Physics, Okayama, Japan
| | - S Short
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - M Smy
- University of California, Irvine, Department of Physics and Astronomy, Irvine, California, USA
| | - J T Sobczyk
- Wroclaw University, Faculty of Physics and Astronomy, Wroclaw, Poland
| | - M Sorel
- IFIC (CSIC and University of Valencia), Valencia, Spain
| | - L Southwell
- Lancaster University, Physics Department, Lancaster, United Kingdom
| | - P Stamoulis
- IFIC (CSIC and University of Valencia), Valencia, Spain
| | - J Steinmann
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - T Stewart
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - Y Suda
- University of Tokyo, Department of Physics, Tokyo, Japan
| | - S Suvorov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | | | - K Suzuki
- Kyoto University, Department of Physics, Kyoto, Japan
| | - S Y Suzuki
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - Y Suzuki
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - R Tacik
- University of Regina, Department of Physics, Regina, Saskatchewan, Canada
- TRIUMF, Vancouver, British Columbia, Canada
| | - M Tada
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - S Takahashi
- Kyoto University, Department of Physics, Kyoto, Japan
| | - A Takeda
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - Y Takeuchi
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
- Kobe University, Kobe, Japan
| | - H K Tanaka
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - H A Tanaka
- University of Toronto, Department of Physics, Toronto, Ontario, Canada
- TRIUMF, Vancouver, British Columbia, Canada
| | - D Terhorst
- RWTH Aachen University, III. Physikalisches Institut, Aachen, Germany
| | - R Terri
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - T Thakore
- Louisiana State University, Department of Physics and Astronomy, Baton Rouge, Louisiana, USA
| | - L F Thompson
- University of Sheffield, Department of Physics and Astronomy, Sheffield, United Kingdom
| | - S Tobayama
- University of British Columbia, Department of Physics and Astronomy, Vancouver, British Columbia, Canada
| | - W Toki
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - T Tomura
- University of Tokyo, Institute for Cosmic Ray Research, Kamioka Observatory, Kamioka, Japan
| | - C Touramanis
- University of Liverpool, Department of Physics, Liverpool, United Kingdom
| | - T Tsukamoto
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - M Tzanov
- Louisiana State University, Department of Physics and Astronomy, Baton Rouge, Louisiana, USA
| | - Y Uchida
- Imperial College London, Department of Physics, London, United Kingdom
| | - A Vacheret
- Oxford University, Department of Physics, Oxford, United Kingdom
| | - M Vagins
- University of California, Irvine, Department of Physics and Astronomy, Irvine, California, USA
- Kavli Institute for the Physics and Mathematics of the Universe (WPI), University of Tokyo Institutes for Advanced Study, University of Tokyo, Kashiwa, Chiba, Japan
| | - Z Vallari
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - G Vasseur
- IRFU, CEA Saclay, Gif-sur-Yvette, France
| | - T Wachala
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - K Wakamatsu
- Osaka City University, Department of Physics, Osaka, Japan
| | - C W Walter
- Duke University, Department of Physics, Durham, North Carolina, USA
| | - D Wark
- Oxford University, Department of Physics, Oxford, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - W Warzycha
- University of Warsaw, Faculty of Physics, Warsaw, Poland
| | - M O Wascko
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
- Imperial College London, Department of Physics, London, United Kingdom
| | - A Weber
- Oxford University, Department of Physics, Oxford, United Kingdom
- STFC, Rutherford Appleton Laboratory, Harwell Oxford, and Daresbury Laboratory, Warrington, United Kingdom
| | - R Wendell
- Kyoto University, Department of Physics, Kyoto, Japan
| | - R J Wilkes
- University of Washington, Department of Physics, Seattle, Washington, USA
| | - M J Wilking
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - C Wilkinson
- University of Bern, Albert Einstein Center for Fundamental Physics, Laboratory for High Energy Physics (LHEP), Bern, Switzerland
| | - J R Wilson
- Queen Mary University of London, School of Physics and Astronomy, London, United Kingdom
| | - R J Wilson
- Colorado State University, Department of Physics, Fort Collins, Colorado, USA
| | - Y Yamada
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Yamamoto
- Osaka City University, Department of Physics, Osaka, Japan
| | - M Yamamoto
- Kyoto University, Department of Physics, Kyoto, Japan
| | - C Yanagisawa
- State University of New York at Stony Brook, Department of Physics and Astronomy, Stony Brook, New York, USA
| | - T Yano
- Kobe University, Kobe, Japan
| | - S Yen
- TRIUMF, Vancouver, British Columbia, Canada
| | - N Yershov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, Russia
| | - M Yokoyama
- University of Tokyo, Department of Physics, Tokyo, Japan
| | - J Yoo
- Louisiana State University, Department of Physics and Astronomy, Baton Rouge, Louisiana, USA
| | - K Yoshida
- Kyoto University, Department of Physics, Kyoto, Japan
| | - T Yuan
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - M Yu
- York University, Department of Physics and Astronomy, Toronto, Ontario, Canada
| | - A Zalewska
- H. Niewodniczanski Institute of Nuclear Physics PAN, Cracow, Poland
| | - J Zalipska
- National Centre for Nuclear Research, Warsaw, Poland
| | - L Zambelli
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, Japan
| | - K Zaremba
- Warsaw University of Technology, Institute of Radioelectronics, Warsaw, Poland
| | - M Ziembicki
- Warsaw University of Technology, Institute of Radioelectronics, Warsaw, Poland
| | - E D Zimmerman
- University of Colorado at Boulder, Department of Physics, Boulder, Colorado, USA
| | - M Zito
- IRFU, CEA Saclay, Gif-sur-Yvette, France
| | - J Żmuda
- Wroclaw University, Faculty of Physics and Astronomy, Wroclaw, Poland
| |
Collapse
|
216
|
Song XW, Wang XW, Gao HL, Zhang JX, Yu M, Cheng MK, Shen BS. Apoptosis is related to imbalance of Th1/Th2-type cytokine in peripheral blood mononuclear cells of patients with chronic hepatitis B. Acta Virol 2016; 56:153-4. [PMID: 22720708 DOI: 10.4149/av_2012_02_153] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
KEYWORDS peripheral blood mononuclear cells; apoptosis; cytokine; hepatitis B virus.
Collapse
|
217
|
Fang B, Yu M, Zhang W, Wang F. A new alternative to cosmetics preservation and the effect of the particle size of the emulsion droplets on preservation efficacy. Int J Cosmet Sci 2016; 38:496-503. [DOI: 10.1111/ics.12317] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2016] [Accepted: 03/01/2016] [Indexed: 12/26/2022]
Affiliation(s)
- B. Fang
- School of Perfume and Aroma Technology; Shanghai Institute of Technology; No.100, Haiquan Road Fengxian district Shanghai 201418 China
| | - M. Yu
- Shanghai Syntec Additive Limited; No.168, Jixin Road Minhang district Shanghai 201104 China
| | - W. Zhang
- School of Perfume and Aroma Technology; Shanghai Institute of Technology; No.100, Haiquan Road Fengxian district Shanghai 201418 China
| | - F. Wang
- Shanghai Syntec Additive Limited; No.168, Jixin Road Minhang district Shanghai 201104 China
| |
Collapse
|
218
|
Yu M, Van Brunt K, Varnado OJ, Boye KS. Patient-reported outcome results in patients with type 2 diabetes treated with once-weekly dulaglutide: data from the AWARD phase III clinical trial programme. Diabetes Obes Metab 2016; 18:419-24. [PMID: 26691396 DOI: 10.1111/dom.12624] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2015] [Revised: 12/09/2015] [Accepted: 12/16/2015] [Indexed: 01/23/2023]
Abstract
We evaluated patient-reported outcome (PRO) measures from the Assessment of Weekly AdministRation of LY2189265 (dulaglutide) in Diabetes (AWARD) clinical trial programme for dulaglutide (1.5 mg and 0.75 mg) in patients with type 2 diabetes (T2D). The Impact of Weight on Self-Perception (IW-SP), Impact of Weight on Ability to Perform Physical Activities of Daily Living (APPADL), Impact of Weight on Quality of Life-Lite, EQ-5D, Diabetes Treatment Satisfaction Questionnaire (DTSQ), Diabetes Symptom Checklist-Revised and Adult Low Blood Sugar Survey were administered and analysed for changes from baseline in one or more AWARD studies. Significant within-group changes from baseline to the primary time point were observed for several PRO measures across all studies. Compared with insulin glargine, significantly greater improvements in the IW-SP score were observed with dulaglutide 1.5 mg and with both dulaglutide doses in the APPADL score. Both dulaglutide doses resulted in significantly greater improvement in DTSQ scores (all subscales) compared with exenatide. Dulaglutide 1.5 mg also resulted in significantly greater improvement on the DTSQ hyperglycaemia subscale compared with metformin. Overall, these PRO results suggest that dulaglutide is beneficial in the treatment of T2D.
Collapse
Affiliation(s)
- M Yu
- Eli Lilly and Company, Toronto, Canada
| | | | - O J Varnado
- Lilly Diabetes, Eli Lilly and Company, Indianapolis, IN, USA
| | - K S Boye
- Lilly Diabetes, Eli Lilly and Company, Indianapolis, IN, USA
| |
Collapse
|
219
|
Shen Q, Jiang QF, Tian YW, Yu M, Jia JK, Xue HZ. [Observation on the efficacy of modified Appleby operation for carcinoma of the body and tail of the pancreas]. Zhonghua Yi Xue Za Zhi 2016; 96:431-4. [PMID: 26875917 DOI: 10.3760/cma.j.issn.0376-2491.2016.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
OBJECTIVE To evaluate the security, feasibility and therapeutic efficacy of modified Appleby operation for carcinoma of the body and tail of pancreas. METHODS From March 2010 to February 2015 modified Appleby operation was performed in 17 patients with carcinoma of the body and tail of the pancreas. The biochemical indices of fasting plasma blood (FPB), body weight (BW), visual analogue pain intensity scale (VAS score) and the quality of life index were evaluated before and 1 day , 1, 2, 6weeks after surgery. Survival time, tumor recurrence time, hospitalization time and treatment-related complications were analyzed. RESULTS There was no hospital mortality in this study. Pancreatic fistula and diarrhea were the major complications. The overall complication rate was 47.1%. The liver function index of ALT and AST were increased on postoperative day 1, and they were restored to normal after one week. Blood glucose has no obvious abnormal increase and abdominal pain was completely relieved. The VAS score decreased after surgery comparing with before (1.9±3.6 vs 83.2±8.5, P<0.05). Life quality assessment was significantly higher. The body weight of patients after surgery has a mean increment of (4.1±1.3)kg than that before surgery (68.1±4.3 vs 64.0±6.7, P<0.05). A significant rise of the overall quality of life index was observed after surgery (93.8±9.7 vs 68.6±6.7, P<0.05). The recurrence rates of 1, 2, 3 and 5 years were 22.9%, 58.9%, 72.6% and 72.6%, respectively. Median recurrence time was (20.0±3.8 m) (95%CI: 12.6-27.4 m). The survival rates of 1, 2, 3 and 5 years were 80.4%, 54.2%, 32.5% and 16.3%, respectively. The median survival time was (26.0±6.0)m (95%CI: 14.2-37.8 m). CONCLUSIONS Modified Appleby operation for pancreatic cancer is safe and feasible. It can relieve abdominal pain, improve the quality of life, improve the survival rate and prolong the survival time.
Collapse
Affiliation(s)
- Q Shen
- Department of General Surgery, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | | | | | | | | | | |
Collapse
|
220
|
Abstract
Tri-ortho-cresyl phosphate (TOCP) has been widely used as plasticizers, plastic softeners, and flame retardants in industry and reported to have delayed neurotoxicity and reproductive toxicology in animals. However, it remains to be elusive whether TOCP induces liver injury. In this study, male mice were orally administered different concentrations of TOCP (100, 200, or 400 mg/kg/day) for 28 days. Histological examination showed that TOCP led to serious hepatocellular injury. In addition, administration of TOCP induced a marked elevation in the serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in mice. The content of malondialdehyde (MDA) was increased significantly in the liver after the mice were treated with TOCP; while there was a dramatic decrease in the content of glutathione (GSH) and the activities of antioxidative enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX). TOCP inhibited viability of mouse liver cancer Hepa 1-6 cells in a dose-dependent manner. Meanwhile, TOCP significantly increased MDA content and inhibited GSH content and the activities of SOD and GSH-PX in the cells, respectively. Oxidative stress dramatically inhibited viability of Hepa 1-6 cells; while inhibition of oxidative stress by N-acetyl-l-cysteine could rescue the cell viability inhibited by TOCP to a certain extent. In summary, oxidative stress might be involved in TOCP-induced hepatocellular injury in male mice.
Collapse
Affiliation(s)
- L L Xu
- Medical Research Center, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China
| | - C Y Long
- Department of Physiology, Medical College of Nanchang University, Nanchang, People's Republic of China Department of Clinical Medicine, Fuzhou Medical College of Nanchang University, Fuzhou, People's Republic of China
| | - J L Wang
- Department of Physiology, Medical College of Nanchang University, Nanchang, People's Republic of China
| | - M Yu
- Library, Medical College of Nanchang University, Nanchang, People's Republic of China
| | - J X Chen
- Department of Physiology, Medical College of Nanchang University, Nanchang, People's Republic of China
| |
Collapse
|
221
|
Ji Y, Xin G, Qu Z, Zou X, Yu M. Mechanism of juglone-induced apoptosis of MCF-7 cells by the mitochondrial pathway. Genet Mol Res 2016; 15:gmr8785. [DOI: 10.4238/gmr.15038785] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
222
|
Dong RH, Qin CC, Qiu X, Yan X, Yu M, Cui L, Zhou Y, Zhang HD, Jiang XY, Long YZ. In situ precision electrospinning as an effective delivery technique for cyanoacrylate medical glue with high efficiency and low toxicity. Nanoscale 2015; 7:19468-75. [PMID: 26531687 DOI: 10.1039/c5nr05786h] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
The side effects or toxicity of cyanoacrylate used in vivo have been argued since its first application in wound closure. We propose an airflow-assisted in situ precision electrospinning apparatus as an applicator and make a detailed comparison with traditional spraying via in vitro and in vivo experiments. This novel method can not only improve operational performance and safety by precisely depositing cyanoacrylate fibers onto a wound, but significantly reduce the dosage of cyanoacrylate by almost 80%. A white blood cell count, liver function test and histological analysis prove that the in situ precision electrospinning applicator produces a better postoperative outcome, e.g., minor hepatocyte injury, moderate inflammation and the significant ability for liver regeneration. This in situ precision electrospinning method may thus dramatically broaden both civilian and military applications of cyanoacrylates.
Collapse
Affiliation(s)
- R H Dong
- Collaborative Innovation Center for Low-Dimensional Nanomaterials & Optoelectronic Devices, College of Physics, Qingdao University, Qingdao 266071, P. R. China.
| | - C C Qin
- Collaborative Innovation Center for Low-Dimensional Nanomaterials & Optoelectronic Devices, College of Physics, Qingdao University, Qingdao 266071, P. R. China.
| | - X Qiu
- Medical College, Qingdao University, Qingdao 266071, P. R. China.
| | - X Yan
- Collaborative Innovation Center for Low-Dimensional Nanomaterials & Optoelectronic Devices, College of Physics, Qingdao University, Qingdao 266071, P. R. China.
| | - M Yu
- Collaborative Innovation Center for Low-Dimensional Nanomaterials & Optoelectronic Devices, College of Physics, Qingdao University, Qingdao 266071, P. R. China. and Department of Mechanical Engineering, Columbia University, New York 10027, USA
| | - L Cui
- Medical College, Qingdao University, Qingdao 266071, P. R. China.
| | - Y Zhou
- Medical College, Qingdao University, Qingdao 266071, P. R. China.
| | - H D Zhang
- Collaborative Innovation Center for Low-Dimensional Nanomaterials & Optoelectronic Devices, College of Physics, Qingdao University, Qingdao 266071, P. R. China.
| | - X Y Jiang
- Laboratory for Biological Effects of Nanomaterials & Nanosafety, National Center for Nanoscience & Technology, Beijing 100190, P. R. China.
| | - Y Z Long
- Collaborative Innovation Center for Low-Dimensional Nanomaterials & Optoelectronic Devices, College of Physics, Qingdao University, Qingdao 266071, P. R. China. and Collaborative Innovation Center for Marine Biomass Fibers, Materials and Textiles of Shandong Province, Qingdao University, Qingdao 266071, P. R. China
| |
Collapse
|
223
|
Li S, Lam J, Zhang J, Chan J, Yu M, Wing Y. Symptoms of insomnia in patients with obstructive sleep apnea: Prevalence, correlates and association with suicidality. Sleep Med 2015. [DOI: 10.1016/j.sleep.2015.02.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
224
|
Li S, Lam J, Zhang J, Yu M, Chan J, Chan C, Espie C, Freeman D, Mason O, Wing Y. Can sleep disturbances predict suicide risk in patients with schizophrenia-spectrum disorders? A 8-year naturalistic longitudinal study. Sleep Med 2015. [DOI: 10.1016/j.sleep.2015.02.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
225
|
|
226
|
Abstract
One-dimensional icosahedral boron chains and two-dimensional icosahedral boron sheets (icosahedral α, δ6, and δ4 sheets) that contain icosahedra B12 as their building units have been predicted in a computer simulation study using a state-of-the-art semi-empirical Hamiltonian. These novel low-dimensional icosahedral structures exhibit interesting bonding and electronic properties. Specifically, the three-center, two-electron bonding between icosahedra B12 of the boron bulk (rhombohedral boron) transforms into a two-center bonding in these new allotropes of boron sheets. In contrast to the previously reported stable buckled α and triangular boron monolayer sheets, these new allotropes of boron sheets form a planar network. Calculations of electronic density of states (DOS) reveal a semiconducting nature for both the icosahedral chain and the icosahedral δ6 and δ4 sheets, as well as a nearly gapless (or metallic-like) feature in the DOS for the icosahedral α sheet. The results for the energy barrier per atom between the icosahedral δ6 and α sheets (0.17 eV), the icosahedral δ6 and δ4 sheets (0.38 eV), and the icosahedral α and δ4 sheets (0.27 eV), as indicated in the respective parentheses, suggest that these new allotropes of boron sheets are relatively stable.
Collapse
Affiliation(s)
- C B Kah
- Department of Physics and Astronomy, University of Louisville, Louisville, Kentucky, 40292, USA
| | | | | | | | | |
Collapse
|
227
|
Wu Q, Yu M, Ji X, Diao H, Liu Q. Changes in Cx 43 expressions in Sertolic cell by benzo(a)pyrene exposure. Toxicol Lett 2015. [DOI: 10.1016/j.toxlet.2015.08.830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
228
|
|
229
|
Reaney M, Yu M, Lakshmanan M, Pechtner V, van Brunt K. Treatment satisfaction in people with type 2 diabetes mellitus treated with once-weekly dulaglutide: data from the AWARD-1 and AWARD-3 clinical trials. Diabetes Obes Metab 2015; 17:896-903. [PMID: 26095190 DOI: 10.1111/dom.12527] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/19/2015] [Revised: 03/21/2015] [Accepted: 06/12/2015] [Indexed: 12/15/2022]
Abstract
AIMS To compare treatment satisfaction among people with type 2 diabetes receiving dulaglutide 1.5 mg and dulaglutide 0.75 mg (a once-weekly, long-acting, glucagon-like peptide-1 receptor agonist) with those receiving either exenatide or placebo (AWARD-1 study) or metformin (AWARD-3 study) over 52 weeks. METHODS The Diabetes Treatment Satisfaction Questionnaire status version (DTSQs) and change version (DTSQc) were used to evaluate total treatment satisfaction and perceived frequency of hyperglycaemia and hypoglycaemia. RESULTS In the AWARD-1 study, significant improvements from baseline were observed in total DTSQs score for both dulaglutide doses (26 and 52 weeks) and exenatide (26 weeks). The improvement was significantly greater with both dulaglutide doses compared with placebo (26 weeks) and exenatide (26 and 52 weeks). The perceived frequency of hyperglycaemia was lower for all groups at 26 and 52 weeks compared with baseline. The improvement was greater with both dulaglutide doses and exenatide compared with placebo at 26 weeks, and was also greater with both dulaglutide doses compared with exenatide at 26 and 52 weeks. The exenatide group had an increase in perceived frequency of hypoglycaemia at 26 and 52 weeks. In the AWARD-3 study, significant improvements from baseline were observed for total DTSQs scores in all groups at 26 and 52 weeks. Perceived frequency of hyperglycaemia was lower for all groups at 26 and 52 weeks compared with baseline, and this improvement was greater with both dulaglutide doses compared with metformin at 52 weeks. CONCLUSIONS Dulaglutide was associated with improvements in treatment satisfaction and a decrease in perceived frequency of hyperglycaemia.
Collapse
Affiliation(s)
| | - M Yu
- Eli Lilly and Company, Toronto, Canada
| | - M Lakshmanan
- Lilly Diabetes, Eli Lilly and Company, Indianapolis, IN, USA
| | - V Pechtner
- Lilly Diabetes, Eli Lilly and Company, Neuilly-sur-Seine, France
| | | |
Collapse
|
230
|
Jiang J, Lan YQ, Zhang T, Yu M, Liu XY, Li LH, Chen XP. The in vitro effects of caffeine on viability, cycle cycle profiles, proliferation, and apoptosis of glioblastomas. Eur Rev Med Pharmacol Sci 2015; 19:3201-3207. [PMID: 26400523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
OBJECTIVE We studied the effects of caffeine on cell viability, cell cycle profiles, proliferation, and apoptosis in rat C6 and human U87MG glioblastoma cell lines. MATERIALS AND METHODS Cell viability was quantified by the methyl thiazolyl tetrazolium (MTT) assay. Flow cytometry was used to quantify the relative number of cells in different phases of the cell cycle, while cell proliferation was quantified using the Cell Counting Kit-8. The proportion of apoptotic cells was determined by flow cytometry, and expression of apoptosis-related proteins Caspase-3, Cyt-C, Bax and Bcl-2 by Western blot. RESULTS Caffeine at doses of up to 0.5 mM did not affect cell viability in both rat C6 and human U87MG glioblastoma cells. Further studies were done using the dose of 0.5 mM. Percentage of cells in the G0/G1 phase was markedly increased, while percentage of cells in the S phase decreased, after cell treatment with caffeine. Cell proliferation was significantly inhibited by caffeine. Furthermore, caffeine induced cell apoptosis, decreased expression of Bcl-2, and increased expression of Cyt-C and Caspase-3. CONCLUSIONS Caffeine inhibits proliferation and induces apoptosis in glioblastoma cells. Our results provide the experimental basis for further studies of potential role of caffeine in the treatment of glioblastomas.
Collapse
Affiliation(s)
- J Jiang
- Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P.R. China.
| | | | | | | | | | | | | |
Collapse
|
231
|
Huang SW, Yang J, Lim J, Zhou H, Yu M, Kwong DL, Wong CW. A low-phase-noise 18 GHz Kerr frequency microcomb phase-locked over 65 THz. Sci Rep 2015; 5:13355. [PMID: 26311406 PMCID: PMC4550847 DOI: 10.1038/srep13355] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2015] [Accepted: 07/23/2015] [Indexed: 11/27/2022] Open
Abstract
Laser frequency combs are coherent light sources that simultaneously provide pristine frequency spacings for precision metrology and the fundamental basis for ultrafast and attosecond sciences. Recently, nonlinear parametric conversion in high-Q microresonators has been suggested as an alternative platform for optical frequency combs, though almost all in 100 GHz frequencies or more. Here we report a low-phase-noise on-chip Kerr frequency comb with mode spacing compatible with high-speed silicon optoelectronics. The waveguide cross-section of the silicon nitride spiral resonator is designed to possess small and flattened group velocity dispersion, so that the Kerr frequency comb contains a record-high number of 3,600 phase-locked comb lines. We study the single-sideband phase noise as well as the long-term frequency stability and report the lowest phase noise floor achieved to date with -130 dBc/Hz at 1 MHz offset for the 18 GHz Kerr comb oscillator, along with feedback stabilization to achieve frequency Allan deviations of 7 × 10(-11) in 1 s. The reported system is a promising compact platform for achieving self-referenced Kerr frequency combs and also for high-capacity coherent communication architectures.
Collapse
Affiliation(s)
- S.-W. Huang
- Mesoscopic Optics and Quantum Electronics Laboratory, University of California, Los Angeles, CA, USA
- Optical Nanostructures Laboratory, Center for Integrated Science and Engineering, Solid-State Science and Engineering, and Mechanical Engineering, Columbia University, New York, NY, USA
| | - J. Yang
- Mesoscopic Optics and Quantum Electronics Laboratory, University of California, Los Angeles, CA, USA
- Optical Nanostructures Laboratory, Center for Integrated Science and Engineering, Solid-State Science and Engineering, and Mechanical Engineering, Columbia University, New York, NY, USA
| | - J. Lim
- Mesoscopic Optics and Quantum Electronics Laboratory, University of California, Los Angeles, CA, USA
| | - H. Zhou
- University of Electronic Science and Technology of China, Chengdu, Sichuan, China
| | - M. Yu
- Institute of Microelectronics, Singapore, Singapore
| | - D.-L. Kwong
- Institute of Microelectronics, Singapore, Singapore
| | - C. W. Wong
- Mesoscopic Optics and Quantum Electronics Laboratory, University of California, Los Angeles, CA, USA
- Optical Nanostructures Laboratory, Center for Integrated Science and Engineering, Solid-State Science and Engineering, and Mechanical Engineering, Columbia University, New York, NY, USA
| |
Collapse
|
232
|
Bright DR, Kisor DF, Smith A, Conaway M, Yu M. Implementation of a pharmacogenetic management service for postmyocardial infarction care in a community pharmacy. Per Med 2015; 12:319-325. [PMID: 29771653 DOI: 10.2217/pme.15.7] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
AIM The purpose of this study was to pilot a multisite, proof-of-concept model where community pharmacists could engage patients and physicians to provide pharmacogenetic (PGt) testing and clinical decision support. PATIENTS & METHODS Patients with history of acute myocardial infarction and percutaneous coronary intervention with no prior history of CYP2C19 testing. RESULTS Four community pharmacies provided pharmacogenetic testing and medication therapy management services to 30 patients, resulting in eight recommendations for antiplatelet therapy adjustment. CONCLUSION Pharmacists involved in the study were able to facilitate antiplatelet therapy adjustments based on PGt data regardless of baseline antiplatelet drug selection. Whereas prior literature largely revolved around PGt management in the inpatient setting, this project supports the involvement of the community pharmacist in making PGt-based recommendations.
Collapse
Affiliation(s)
- D R Bright
- Department of Pharmaceutical Sciences, Ferris State University College of Pharmacy, 220 Ferris Dr, Big Rapids, MI 49307, USA
| | - D F Kisor
- Department of Pharmaceutical Sciences, Manchester University College of Pharmacy, 10627 Diebold Rd, Fort Wayne, IN 46845, USA
| | - A Smith
- Raabe College of Pharmacy, Ohio Northern University, 525 South Main Street, Ada, OH 45810, USA
| | - M Conaway
- Kroger Pharmacy, 101 Sixth Street, Findlay, OH 45840, USA
| | - M Yu
- Kroger Pharmacy, 101 Sixth Street, Findlay, OH 45840, USA
| |
Collapse
|
233
|
Luo X, Lei Y, He L, Liu W, Li M, Ran L, Yu M, Guo X, Yu P, Liu Z, Cheng Z. No influence of CYP2D6*10 genotype and phenotype on the pharmacokinetics of nebivolol in healthy Chinese subjects. J Clin Pharm Ther 2015. [PMID: 26214065 DOI: 10.1111/jcpt.12310] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
WHAT IS KNOWN AND OBJECTIVE Nebivolol, a clinically important antihypertensive drug, mainly metabolized by cytochrome P450 (CYP) 2D6, shows wide interindividual variability in pharmacokinetics. The CYP2D6*10 allele (100C>T; rs1065852), present at a high frequency in the Chinese population, is associated with alteration in the pharmacokinetics of many drugs, but its effect on the pharmacokinetics of nebivolol is unknown. The aim of our study was to investigate whether the CYP2D6*10 genotype and phenotype are associated with changes in the pharmacokinetics of nebivolol in Chinese subjects. METHODS Twenty-four healthy subjects were divided into three groups according to CYP2D6*1/*1 (n = 7), CYP2D6*1/*10 (n = 5) and CYP2D6*10/*10 (n = 12) genotypes. The *1/*1 homozygotes and *1/*10 heterozygotes were C allele carriers. All subjects received oral single dose of nebivolol and dextromethorphan. Blood and urine samples were gathered at various times. RESULTS There were no statistically significant differences in the pharmacokinetics of nebivolol between the three CYP2D6*10 genotypes, and no gene-dose effect was seen. The pharmacokinetic parameters of CYP2D6*10/*10 subjects were also similar to those of CYP2D6*1 carriers. A weak relationship between CYP2D6 phenotype and nebivolol clearance was found. WHAT IS NEW AND CONCLUSION The CYP2D6*10 genotype and phenotype were not associated with significant alterations in the pharmacokinetics of nebivolol. CYP2D6*10 alone does not account for the large interindividual differences observed in the disposition of nebivolol among Chinese healthy subjects.
Collapse
Affiliation(s)
- X Luo
- School of Life Sciences, Central South University, Changsha, China.,Research Institute of Drug Metabolism and Pharmacokinetics, School of Pharmaceutical Sciences, Central South University, Changsha, China
| | - Y Lei
- Research Institute of Drug Metabolism and Pharmacokinetics, School of Pharmaceutical Sciences, Central South University, Changsha, China.,Haikou People's Hospital and Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou, China
| | - L He
- Research Institute of Drug Metabolism and Pharmacokinetics, School of Pharmaceutical Sciences, Central South University, Changsha, China
| | - W Liu
- Research Institute of Drug Metabolism and Pharmacokinetics, School of Pharmaceutical Sciences, Central South University, Changsha, China
| | - M Li
- Research Institute of Drug Metabolism and Pharmacokinetics, School of Pharmaceutical Sciences, Central South University, Changsha, China
| | - L Ran
- Hunan Tiger Xiangya R&D Co., Ltd, Changsha, China
| | - M Yu
- Hunan Tiger Xiangya R&D Co., Ltd, Changsha, China
| | - X Guo
- Hunan Tiger Xiangya R&D Co., Ltd, Changsha, China
| | - P Yu
- Research Institute of Drug Metabolism and Pharmacokinetics, School of Pharmaceutical Sciences, Central South University, Changsha, China
| | - Z Liu
- Hunan Tiger Xiangya R&D Co., Ltd, Changsha, China
| | - Z Cheng
- Research Institute of Drug Metabolism and Pharmacokinetics, School of Pharmaceutical Sciences, Central South University, Changsha, China
| |
Collapse
|
234
|
Zhang HD, Yu M, Zhang JC, Sheng CH, Yan X, Han WP, Liu YC, Chen S, Shen GZ, Long YZ. Fabrication and photoelectric properties of La-doped p-type ZnO nanofibers and crossed p-n homojunctions by electrospinning. Nanoscale 2015; 7:10513-10518. [PMID: 26008851 DOI: 10.1039/c5nr02191j] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
La-doped p-type ZnO nanofibers were successfully synthesized by electrospinning, followed by calcination. The microstructure and morphology of the La-doped ZnO nanofibers were characterized by scanning electron microscopy (SEM), X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS) and Raman spectroscopy. The field effect curve of individual nanofibers confirms that the resulting La-doped ZnO fibers are p-type semiconductors. The doping mechanism is discussed. Furthermore, crossed p-n homojunction nanofibers were also prepared based on electrospun La-doped p-type ZnO and n-type pure ZnO fibers. The current-voltage curve shows the typical rectifying characteristic of a p-n homojunction device. The turn-on voltage appears at about 2.5 V under the forward bias and the reverse current is impassable.
Collapse
Affiliation(s)
- H D Zhang
- College of Physics & Collaborative Innovation Center for Low-Dimensional Nanomaterials and Optoelectronic Devices, Qingdao University, Qingdao 266071, China.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
235
|
Abe K, Adam J, Aihara H, Andreopoulos C, Aoki S, Ariga A, Assylbekov S, Autiero D, Barbi M, Barker G, Barr G, Bartet-Friburg P, Bass M, Batkiewicz M, Bay F, Berardi V, Berger B, Berkman S, Bhadra S, Blaszczyk F, Blondel A, Bolognesi S, Bordoni S, Boyd S, Brailsford D, Bravar A, Bronner C, Buchanan N, Calland R, Caravaca Rodríguez J, Cartwright S, Castillo R, Catanesi M, Cervera A, Cherdack D, Chikuma N, Christodoulou G, Clifton A, Coleman J, Coleman S, Collazuol G, Connolly K, Cremonesi L, Dabrowska A, Das R, Davis S, de Perio P, De Rosa G, Dealtry T, Dennis S, Densham C, Dewhurst D, Di Lodovico F, Di Luise S, Dolan S, Drapier O, Duffy K, Dumarchez J, Dytman S, Dziewiecki M, Emery-Schrenk S, Ereditato A, Escudero L, Feusels T, Finch A, Fiorentini G, Friend M, Fujii Y, Fukuda Y, Furmanski A, Galymov V, Garcia A, Giffin S, Giganti C, Gilje K, Goeldi D, Golan T, Gonin M, Grant N, Gudin D, Hadley D, Haegel L, Haesler A, Haigh M, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings N, Hayashino T, Hayato Y, Helmer R, Hierholzer M, Hignight J, Hillairet A, Himmel A, Hiraki T, Hirota S, Holeczek J, Horikawa S, Hosomi F, Huang K, Ichikawa A, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Irvine T, Ishida T, Ishii T, Iwai E, Iwamoto K, Iyogi K, Izmaylov A, Jacob A, Jamieson B, Jiang M, Johnson S, Jo J, Jonsson P, Jung C, Kabirnezhad M, Kaboth A, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Katori T, Kearns E, Khabibullin M, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim J, King S, Kisiel J, Kitching P, Kobayashi T, Koch L, Koga T, Kolaceke A, Konaka A, Kopylov A, Kormos L, Korzenev A, Koshio Y, Kropp W, Kubo H, Kudenko Y, Kurjata R, Kutter T, Lagoda J, Lamont I, Larkin E, Laveder M, Lawe M, Lazos M, Lindner T, Lister C, Litchfield R, Longhin A, Lopez J, Ludovici L, Magaletti L, Mahn K, Malek M, Manly S, Marino A, Marteau J, Martin J, Martins P, Martynenko S, Maruyama T, Matveev V, Mavrokoridis K, Mazzucato E, McCarthy M, McCauley N, McFarland K, McGrew C, Mefodiev A, Metelko C, Mezzetto M, Mijakowski P, Miller C, Minamino A, Mineev O, Mine S, Missert A, Miura M, Moriyama S, Mueller T, Murakami A, Murdoch M, Murphy S, Myslik J, Nakadaira T, Nakahata M, Nakamura K, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, Nowak J, O’Keeffe H, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser S, Ovsyannikova T, Owen R, Oyama Y, Palladino V, Palomino J, Paolone V, Payne D, Perevozchikov O, Perkin J, Petrov Y, Pickard L, Pinzon Guerra E, Pistillo C, Plonski P, Poplawska E, Popov B, Posiadala-Zezula M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff P, Ravonel M, Rayner M, Redij A, Reeves M, Reinherz-Aronis E, Riccio C, Rodrigues P, Rojas P, Rondio E, Roth S, Rubbia A, Ruterbories D, Rychter A, Sacco R, Sakashita K, Sánchez F, Sato F, Scantamburlo E, Scholberg K, Schoppmann S, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaikhiev A, Shaker F, Shaw D, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smy M, Sobczyk J, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Suda Y, Suzuki A, Suzuki K, Suzuki S, Suzuki Y, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka H, Tanaka H, Tanaka M, Terhorst D, Terri R, Thompson L, Thorley A, Tobayama S, Toki W, Tomura T, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Vacheret A, Vagins M, Vasseur G, Wachala T, Wakamatsu K, Walter C, Wark D, Warzycha W, Wascko M, Weber A, Wendell R, Wilkes R, Wilking M, Wilkinson C, Williamson Z, Wilson J, Wilson R, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yoo J, Yoshida K, Yuan T, Yu M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman E, Zito M, Żmuda J. Measurement of the electron neutrino charged-current interaction rate on water with the T2K ND280π0detector. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.91.112010] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
236
|
Abe K, Adam J, Aihara H, Andreopoulos C, Aoki S, Ariga A, Assylbekov S, Autiero D, Barbi M, Barker G, Barr G, Bartet-Friburg P, Bass M, Batkiewicz M, Bay F, Berardi V, Berger B, Berkman S, Bhadra S, Blaszczyk F, Blondel A, Bolognesi S, Bordoni S, Boyd S, Brailsford D, Bravar A, Bronner C, Buchanan N, Calland R, Caravaca Rodríguez J, Cartwright S, Castillo R, Catanesi M, Cervera A, Cherdack D, Chikuma N, Christodoulou G, Clifton A, Coleman J, Coleman S, Collazuol G, Connolly K, Cremonesi L, Dabrowska A, Danko I, Das R, Davis S, de Perio P, De Rosa G, Dealtry T, Dennis S, Densham C, Dewhurst D, Di Lodovico F, Di Luise S, Dolan S, Drapier O, Duffy K, Dumarchez J, Dytman S, Dziewiecki M, Emery-Schrenk S, Ereditato A, Escudero L, Ferchichi C, Feusels T, Finch A, Fiorentini G, Friend M, Fujii Y, Fukuda Y, Furmanski A, Galymov V, Garcia A, Giffin S, Giganti C, Gilje K, Goeldi D, Golan T, Gonin M, Grant N, Gudin D, Hadley D, Haegel L, Haesler A, Haigh M, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings N, Hayashino T, Hayato Y, Hearty C, Helmer R, Hierholzer M, Hignight J, Hillairet A, Himmel A, Hiraki T, Hirota S, Holeczek J, Horikawa S, Hosomi F, Huang K, Ichikawa A, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Irvine T, Ishida T, Ishii T, Iwai E, Iwamoto K, Iyogi K, Izmaylov A, Jacob A, Jamieson B, Jiang M, Johnson S, Jo J, Jonsson P, Jung C, Kabirnezhad M, Kaboth A, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Katori T, Kearns E, Khabibullin M, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim J, King S, Kisiel J, Kitching P, Kobayashi T, Koch L, Koga T, Kolaceke A, Konaka A, Kopylov A, Kormos L, Korzenev A, Koshio Y, Kropp W, Kubo H, Kudenko Y, Kurjata R, Kutter T, Lagoda J, Lamont I, Larkin E, Laveder M, Lawe M, Lazos M, Lindner T, Lister C, Litchfield R, Longhin A, Lopez J, Ludovici L, Magaletti L, Mahn K, Malek M, Manly S, Marino A, Marteau J, Martin J, Martins P, Martynenko S, Maruyama T, Matveev V, Mavrokoridis K, Mazzucato E, McCarthy M, McCauley N, McFarland K, McGrew C, Mefodiev A, Metelko C, Mezzetto M, Mijakowski P, Miller C, Minamino A, Mineev O, Missert A, Miura M, Moriyama S, Mueller T, Murakami A, Murdoch M, Murphy S, Myslik J, Nakadaira T, Nakahata M, Nakamura K, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, Nowak J, O’Keeffe H, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser S, Ovsyannikova T, Owen R, Oyama Y, Palladino V, Palomino J, Paolone V, Payne D, Perevozchikov O, Perkin J, Petrov Y, Pickard L, Pinzon Guerra E, Pistillo C, Plonski P, Poplawska E, Popov B, Posiadala-Zezula M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff P, Ravonel M, Rayner M, Redij A, Reeves M, Reinherz-Aronis E, Riccio C, Rodrigues P, Rojas P, Rondio E, Roth S, Rubbia A, Ruterbories D, Rychter A, Sacco R, Sakashita K, Sánchez F, Sato F, Scantamburlo E, Scholberg K, Schoppmann S, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaker F, Shaw D, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smy M, Sobczyk J, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Still B, Suda Y, Suzuki A, Suzuki K, Suzuki S, Suzuki Y, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka H, Tanaka H, Tanaka M, Terhorst D, Terri R, Thompson L, Thorley A, Tobayama S, Toki W, Tomura T, Totsuka Y, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Vacheret A, Vagins M, Vasseur G, Wachala T, Wakamatsu K, Walter C, Wark D, Warzycha W, Wascko M, Weber A, Wendell R, Wilkes R, Wilking M, Wilkinson C, Williamson Z, Wilson J, Wilson R, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yoo J, Yoshida K, Yuan T, Yu M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman E, Zito M, Żmuda J. Measurement of theνμcharged current quasielastic cross section on carbon with the T2K on-axis neutrino beam. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.91.112002] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
237
|
Walker M, Janot A, Grewal H, Yu M, Lammi M, Saketkoo L. SAT0540 Assessment of Factors Protective of Bone Mineral Density in a New Orleans Sarcoidosis Population. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.3619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
238
|
Walker M, Doughty L, Janot A, Grewal H, Yu M, Saketkoo L, Lammi M. THU0556 Smoking and Increased Airway Obstruction Over Time in Patients with Pulmonary Sarcoidosis. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.3625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
239
|
Abstract
We examined the influence of caffeine on the proliferation and apoptosis of β cells cultured in vitro in the presence of the free fatty acid palmitic acid (PA). Different concentrations of caffeine (1-100 mM) and free fatty PA were added to cultured β cells. The MTT assay was used to analyze cell proliferative activity; flow cytometry was used to measure apoptosis and calculate the apoptosis rate. Compared with the blank control group, cells cultured with 500 mM PA for 24, 48, 72, and 96 h showed inhibition of pancreatic β cell proliferative activity. In the 10 and 25 mM caffeine groups cultured for 48, 72, and 96 h, β cell proliferative activity was much higher than that in the 500 mM PA group. The apoptosis rate in the 500 mM PA group was 40.55 ± 20.33%, which was higher than that in the blank control group. The apoptosis rates in the 10 and 25 mM caffeine group and the PA group were 19.12 ± 10.56 and 20.97 ± 9.75%, respectively, which was lower than that in the 500 mM PA group. At some concentrations, caffeine can improve free fatty PA levels and guide pancreatic β cell proliferation inhibition and cell apoptosis.
Collapse
Affiliation(s)
- L Chen
- Department of Endocrinology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - M Yu
- Department of Endocrinology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - T Shen
- Department of Endocrinology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - J Xia
- Department of Endocrinology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| | - B L Xu
- Department of Endocrinology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
| |
Collapse
|
240
|
Jiao Y, Ma R, Yu M. Single nucleotide polymorphism analysis of the endopolygalacturonase gene in peach and its potential use in crossbreeding programs. Genet Mol Res 2015; 14:4090-101. [PMID: 25966181 DOI: 10.4238/2015.april.27.24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Single nucleotide polymorphisms (SNPs) are the most abundant sequence variations found in plant genomes and are widely used as molecular genetic markers in genetic diversity studies and crossbreeding programs. In this study, we examined 113 DNA sequences of the endopolygalacturonase (endo-PG) gene from 67 peach accessions and found a total of 56 SNPs and 6 insertion/deletions (indels), with a frequency of 3, 1, and 3% for the transitions, transversions, and indels, respectively. Meanwhile, the majority of the observed SNPs were found in the intron regions, while only 2 variable sites and a single indel were detected in the exon regions. A dendrogram was obtained using neighbor-joining cluster analysis and divided into 2 main groups, providing evidence that most of the accessions of the clingstone nonmelting flesh phenotypes generally clustered together and were comparatively nonrelated to the "stony hard" peach cultivars, which were in a different branch altogether. Furthermore, 4 major haplotypes were formed and 3 cleaved amplified polymorphic sequence primer sets were mined according to fruit texture and stone adhesion, displaying their potential as candidate molecular markers for discriminating genotypes. This research will assist peach genetic enhancement by introducing a novel crossbreeding strategy.
Collapse
Affiliation(s)
- Y Jiao
- Institute of Horticulture, Jiangsu Academy of Agricultural Sciences/Jiangsu Key Laboratory for Horticultural Crop Genetic Improvement, Nanjing, Jiangsu, China
| | - R Ma
- Institute of Horticulture, Jiangsu Academy of Agricultural Sciences/Jiangsu Key Laboratory for Horticultural Crop Genetic Improvement, Nanjing, Jiangsu, China
| | - M Yu
- Institute of Horticulture, Jiangsu Academy of Agricultural Sciences/Jiangsu Key Laboratory for Horticultural Crop Genetic Improvement, Nanjing, Jiangsu, China
| |
Collapse
|
241
|
Hu PP, Yu M, Liu XG, Chen ZQ, Liu ZJ. [Correlation analysis between the sagittal and coronal parameters of spino-pelvic in Lenke type 1 adolescent idiopathic scoliosis]. Beijing Da Xue Xue Bao Yi Xue Ban 2015; 47:248-252. [PMID: 25882938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
OBJECTIVE To explore the relationship between spino-pelvic sagittal and coronal parameters in Lenke 1 group of adolescent idiopathic scoliosis (AIS). METHODS The subjects were retrospectively collected from 2005 to 2013. On the posteroanterior and lateral radiographs, apical vertebra (AV), Cobb angle of main thoracic curve (MT), pelvic incidence (PI), C7 translation ratio (C7TR) and other sagittal parameters were measured and recorded. Comparison and correlation studies were conducted between these parameters using specific softwares. RESULTS In the study, 51 subjects, including 18 males and 33 females, were recruited, aged (14.9±2.0) years averagely. The apical vertebra ranged from T7 to T11,with mean MT being 49.6°±16.7°, and mean PI 44.7°±6.7°. Significant correlation existed between PI and PT, SS, LL, as well as between LL and SS, TK (P <0.05). Significant differences were found in TK, LL and SS among the different LM groups, but no difference in the other sagittal parameters. AV had no significant correlation with any sagittal parameter. MT was significantly correlated with TK, LL and SS, but its correlation with PI was not significant. CONCLUSION Most of sagittal parameters were significantly correlated in Lenke 1 adolescent idiopathic scoliosis, forming a regulation chain of spine-pelvic sagittal balance on the basis of PI. Significant correlation exists between some sagittal and coronal parameters.
Collapse
Affiliation(s)
- P P Hu
- Department of Orthopedics, Peking University Third Hospital, Beijing 100191
| | - M Yu
- Department of Orthopedics, Peking University Third Hospital, Beijing 100191
| | - X G Liu
- Department of Orthopedics, Peking University Third Hospital, Beijing 100191
| | - Z Q Chen
- Department of Orthopedics, Peking University Third Hospital, Beijing 100191
| | - Z J Liu
- Department of Orthopedics, Peking University Third Hospital, Beijing 100191
| |
Collapse
|
242
|
Lee J, Tomita Y, Chiou V, Lee S, Yu M, Houston N, Lee M, Kohn E, Trepel J. Distinct immune characteristics in women with deleterious germline BRCA1/2 mutations (gBRCAm)-associated high-grade serous ovarian cancer (HGSOC). Gynecol Oncol 2015. [DOI: 10.1016/j.ygyno.2015.01.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
243
|
Abe K, Adam J, Aihara H, Akiri T, Andreopoulos C, Aoki S, Ariga A, Assylbekov S, Autiero D, Barbi M, Barker G, Barr G, Bartet-Friburg P, Bass M, Batkiewicz M, Bay F, Berardi V, Berger B, Berkman S, Bhadra S, Blaszczyk F, Blondel A, Bojechko C, Bolognesi S, Bordoni S, Boyd S, Brailsford D, Bravar A, Bronner C, Buchanan N, Calland R, Caravaca Rodríguez J, Cartwright S, Castillo R, Catanesi M, Cervera A, Cherdack D, Christodoulou G, Clifton A, Coleman J, Coleman S, Collazuol G, Connolly K, Cremonesi L, Dabrowska A, Das R, Davis S, de Perio P, De Rosa G, Dealtry T, Dennis S, Densham C, Dewhurst D, Di Lodovico F, Di Luise S, Dolan S, Drapier O, Duboyski T, Duffy K, Dumarchez J, Dytman S, Dziewiecki M, Emery-Schrenk S, Ereditato A, Escudero L, Feusels T, Finch A, Fiorentini G, Friend M, Fujii Y, Fukuda Y, Furmanski A, Galymov V, Garcia A, Giffin S, Giganti C, Gilje K, Goeldi D, Golan T, Gonin M, Grant N, Gudin D, Hadley D, Haegel L, Haesler A, Haigh M, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings N, Hayashino T, Hayato Y, Hearty C, Helmer R, Hierholzer M, Hignight J, Hillairet A, Himmel A, Hiraki T, Hirota S, Holeczek J, Horikawa S, Huang K, Ichikawa A, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Irvine T, Ishida T, Ishii T, Iwai E, Iwamoto K, Iyogi K, Izmaylov A, Jacob A, Jamieson B, Jiang M, Johnson S, Jo J, Jonsson P, Jung C, Kabirnezhad M, Kaboth A, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Katori T, Kearns E, Khabibullin M, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim J, King S, Kisiel J, Kitching P, Kobayashi T, Koch L, Koga T, Kolaceke A, Konaka A, Kormos L, Korzenev A, Koshio Y, Kropp W, Kubo H, Kudenko Y, Kurjata R, Kutter T, Lagoda J, Lamont I, Larkin E, Laveder M, Lawe M, Lazos M, Lindner T, Lister C, Litchfield R, Longhin A, Lopez J, Ludovici L, Magaletti L, Mahn K, Malek M, Manly S, Marino A, Marteau J, Martin J, Martins P, Martynenko S, Maruyama T, Matveev V, Mavrokoridis K, Mazzucato E, McCarthy M, McCauley N, McFarland K, McGrew C, Mefodiev A, Metelko C, Mezzetto M, Mijakowski P, Miller C, Minamino A, Mineev O, Missert A, Miura M, Moriyama S, Mueller T, Murakami A, Murdoch M, Murphy S, Myslik J, Nakadaira T, Nakahata M, Nakamura K, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, Nowak J, O’Keeffe H, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser S, Ovsyannikova T, Owen R, Oyama Y, Palladino V, Palomino J, Paolone V, Payne D, Perevozchikov O, Perkin J, Petrov Y, Pickard L, Pinzon Guerra E, Pistillo C, Plonski P, Poplawska E, Popov B, Posiadala-Zezula M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff P, Ravonel M, Rayner M, Redij A, Reeves M, Reinherz-Aronis E, Riccio C, Rodrigues P, Rojas P, Rondio E, Roth S, Rubbia A, Ruterbories D, Rychter A, Sacco R, Sakashita K, Sánchez F, Sato F, Scantamburlo E, Scholberg K, Schoppmann S, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaker F, Shaw D, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smy M, Sobczyk J, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Still B, Suda Y, Suzuki A, Suzuki K, Suzuki S, Suzuki Y, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka H, Tanaka H, Tanaka M, Terhorst D, Terri R, Thompson L, Thorley A, Tobayama S, Toki W, Tomura T, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Vacheret A, Vagins M, Vasseur G, Wachala T, Wakamatsu K, Wallbank M, Walter C, Wark D, Warzycha W, Wascko M, Weber A, Wendell R, Wilkes R, Wilking M, Wilkinson C, Williamson Z, Wilson J, Wilson R, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yoshida K, Yuan T, Yu M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman E, Zito M, Żmuda J. Search for short baselineνedisappearance with the T2K near detector. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.91.051102] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
244
|
Ning Y, Cramer JR, Nuermaimaiti A, Svane K, Yu M, Lægsgaard E, Besenbacher F, Xue QK, Ma X, Hammer B, Gothelf KV, Linderoth TR. Selection of conformational states in self-assembled surface structures formed from an oligo(naphthylene–ethynylene) 3-bit binary switch. J Chem Phys 2015; 142:101922. [DOI: 10.1063/1.4908062] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Y. Ning
- Interdisciplinary Nanoscience Center (iNANO) and Danish National Research Foundation: Danish-Chinese Centre for Self-Assembly and Function of Molecular Nanostructures on Surfaces, 8000 Aarhus C, Denmark
- Institute of Physics, The Chinese Academy of Sciences, Beijing 100190, China
| | - J. R. Cramer
- Interdisciplinary Nanoscience Center (iNANO) and Danish National Research Foundation: Danish-Chinese Centre for Self-Assembly and Function of Molecular Nanostructures on Surfaces, 8000 Aarhus C, Denmark
- Department of Chemistry, Aarhus University, 8000 Aarhus C, Denmark
| | - A. Nuermaimaiti
- Interdisciplinary Nanoscience Center (iNANO) and Danish National Research Foundation: Danish-Chinese Centre for Self-Assembly and Function of Molecular Nanostructures on Surfaces, 8000 Aarhus C, Denmark
| | - K. Svane
- Interdisciplinary Nanoscience Center (iNANO) and Danish National Research Foundation: Danish-Chinese Centre for Self-Assembly and Function of Molecular Nanostructures on Surfaces, 8000 Aarhus C, Denmark
- Department of Physics and Astronomy, Aarhus University, 8000 Aarhus C, Denmark
| | - M. Yu
- Interdisciplinary Nanoscience Center (iNANO) and Danish National Research Foundation: Danish-Chinese Centre for Self-Assembly and Function of Molecular Nanostructures on Surfaces, 8000 Aarhus C, Denmark
| | - E. Lægsgaard
- Interdisciplinary Nanoscience Center (iNANO) and Danish National Research Foundation: Danish-Chinese Centre for Self-Assembly and Function of Molecular Nanostructures on Surfaces, 8000 Aarhus C, Denmark
- Department of Physics and Astronomy, Aarhus University, 8000 Aarhus C, Denmark
| | - F. Besenbacher
- Interdisciplinary Nanoscience Center (iNANO) and Danish National Research Foundation: Danish-Chinese Centre for Self-Assembly and Function of Molecular Nanostructures on Surfaces, 8000 Aarhus C, Denmark
- Department of Physics and Astronomy, Aarhus University, 8000 Aarhus C, Denmark
| | - Q.-K. Xue
- Institute of Physics, The Chinese Academy of Sciences, Beijing 100190, China
| | - X. Ma
- Institute of Physics, The Chinese Academy of Sciences, Beijing 100190, China
| | - B. Hammer
- Interdisciplinary Nanoscience Center (iNANO) and Danish National Research Foundation: Danish-Chinese Centre for Self-Assembly and Function of Molecular Nanostructures on Surfaces, 8000 Aarhus C, Denmark
- Department of Physics and Astronomy, Aarhus University, 8000 Aarhus C, Denmark
| | - K. V. Gothelf
- Interdisciplinary Nanoscience Center (iNANO) and Danish National Research Foundation: Danish-Chinese Centre for Self-Assembly and Function of Molecular Nanostructures on Surfaces, 8000 Aarhus C, Denmark
- Department of Chemistry, Aarhus University, 8000 Aarhus C, Denmark
| | - T. R. Linderoth
- Interdisciplinary Nanoscience Center (iNANO) and Danish National Research Foundation: Danish-Chinese Centre for Self-Assembly and Function of Molecular Nanostructures on Surfaces, 8000 Aarhus C, Denmark
- Department of Physics and Astronomy, Aarhus University, 8000 Aarhus C, Denmark
| |
Collapse
|
245
|
Tan Q, Joshua AM, Saggar JK, Yu M, Wang M, Kanga N, Zhang JY, Chen X, Wouters BG, Tannock IF. Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy. Br J Cancer 2015; 112:832-40. [PMID: 25647012 PMCID: PMC4453951 DOI: 10.1038/bjc.2015.17] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2014] [Revised: 12/24/2014] [Accepted: 01/07/2015] [Indexed: 01/07/2023] Open
Abstract
BACKGROUND Autophagy allows recycling of cellular components and may facilitate cell survival after chemotherapy. Pantoprazole inhibits proton pumps and is reported to inhibit autophagy. Here we evaluate the effects of pantoprazole to modify cytotoxicity of the anticancer drug docetaxel, and underlying mechanisms. METHODS Effects of docetaxel±pantoprazole were studied against wild-type and autophagy-deficient PC3 cells and against four human xenografts. Effects of pantoprazole on autophagy were evaluated by quantifying LC3-I, LC3-II and p62 proteins in western blots, and by fluorescent microscopy of cells transfected with RFP-GFP-LC3. The distribution of drug effects and of autophagy was quantified in tumour sections in relation to blood vessels and hypoxia by immunohistochemistry using γH2AX, cleaved caspase-3, Ki67 and LC3/ p62. RESULTS Pantoprazole increased the toxicity of docetaxel in vitro, increased docetaxel-induced expression of γH2AX and cleaved caspase-3, and decreased Ki67 in tumour sections. Pantoprazole increased growth delay of four human xenografts of low, moderate and high sensitivity to docetaxel, with minimal increase in toxicity. Docetaxel led to increased autophagy throughout tumour sections. Pantoprazole inhibited autophagy, and effects of pantoprazole were reduced against genetically modified cells with decreased ability to undergo autophagy. CONCLUSIONS Autophagy is a mechanism of resistance to docetaxel chemotherapy that may be modified by pantoprazole to improve therapeutic index.
Collapse
Affiliation(s)
- Q Tan
- Department of Medical Biophysics, University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
| | - A M Joshua
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Center and University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
- Institute of Medical Science, University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
| | - J K Saggar
- Department of Medical Biophysics, University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
| | - M Yu
- Department of Medical Biophysics, University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
| | - M Wang
- Department of Medical Biophysics, University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
| | - N Kanga
- Department of Medical Biophysics, University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
| | - J Y Zhang
- Department of Medical Biophysics, University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
| | - X Chen
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Center and University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
| | - B G Wouters
- Department of Medical Biophysics, University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
| | - I F Tannock
- Department of Medical Biophysics, University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Center and University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
- Institute of Medical Science, University Health Network, University of Toronto, Toronto, ON, Canada M5G2M9
| |
Collapse
|
246
|
Taheri A, Gao P, Yu M, Cui D, Regan S, Parkin I, Gruber M. A landscape of hairy and twisted: hunting for new trichome mutants in the Saskatoon Arabidopsis T-DNA population. Plant Biol (Stuttg) 2015; 17:384-94. [PMID: 25348773 DOI: 10.1111/plb.12230] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/07/2014] [Accepted: 06/10/2014] [Indexed: 05/13/2023]
Abstract
A total of 88 new Arabidopsis lines with trichome variation were recovered by screening 49,200 single-seed descent T3 lines from the SK activation-tagged population and from a new 20,000-line T-DNA insertion population (called pAG). Trichome variant lines were classified into 12 distinct phenotype categories. Single or multiple T-DNA insertion sites were identified for 89% of these mutant lines. Alleles of the well-known trichome genes TRY, GL2 and TTG1 were recovered with atypical phenotype variation not reported previously. Moreover, atypical gene expression profiles were documented for two additional mutants specifying TRY and GL2 disruptions. In remaining mutants, ten lines were disrupted in genes coding for proteins not implicated in trichome development, five were disrupted in hypothetical proteins and 11 were disrupted in proteins with unknown function. The collection represents new opportunities for the plant biology community to define trichome development more precisely and to refine the function of individual trichome genes.
Collapse
Affiliation(s)
- A Taheri
- Agriculture and Agri-Food Canada, Saskatoon Research Centre, Saskatoon, SK, Canada; College of Agriculture, Human and Natural Sciences, Tennessee State University, 3500 John A. Merritt Blvd., Nashville, TN, 37209-1561
| | | | | | | | | | | | | |
Collapse
|
247
|
Huang SW, Zhou H, Yang J, McMillan JF, Matsko A, Yu M, Kwong DL, Maleki L, Wong CW. Mode-locked ultrashort pulse generation from on-chip normal dispersion microresonators. Phys Rev Lett 2015; 114:053901. [PMID: 25699441 DOI: 10.1103/physrevlett.114.053901] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2014] [Indexed: 05/27/2023]
Abstract
We describe generation of stable mode-locked pulse trains from on-chip normal dispersion microresonators. The excitation of hyperparametric oscillation is facilitated by the local dispersion disruptions induced by mode interactions. The system is then driven from hyperparametric oscillation to the mode-locked state with over 200 nm spectral width by controlled pump power and detuning. With the continuous-wave-driven nonlinearity, the pulses sit on a pedestal, akin to a cavity soliton. We identify the importance of pump detuning and wavelength-dependent quality factors in stabilizing and shaping the pulse structure, to achieve a single pulse inside the cavity. We examine the mode-locking dynamics by numerically solving the master equation and provide analytic solutions under appropriate approximations.
Collapse
Affiliation(s)
- S-W Huang
- Mesoscopic Optics and Quantum Electronics, University of California, Los Angeles, California 90095, USA and Optical Nanostructures Laboratory, Center for Integrated Science and Engineering, Solid-State Science and Engineering, and Mechanical Engineering, Columbia University, New York, New York 10027, USA
| | - H Zhou
- Optical Nanostructures Laboratory, Center for Integrated Science and Engineering, Solid-State Science and Engineering, and Mechanical Engineering, Columbia University, New York, New York 10027, USA
| | - J Yang
- Mesoscopic Optics and Quantum Electronics, University of California, Los Angeles, California 90095, USA and Optical Nanostructures Laboratory, Center for Integrated Science and Engineering, Solid-State Science and Engineering, and Mechanical Engineering, Columbia University, New York, New York 10027, USA
| | - J F McMillan
- Optical Nanostructures Laboratory, Center for Integrated Science and Engineering, Solid-State Science and Engineering, and Mechanical Engineering, Columbia University, New York, New York 10027, USA
| | - A Matsko
- OEwaves Inc., Pasadena, California 91107, USA
| | - M Yu
- Institute of Microelectronics, Singapore 117685, Singapore
| | - D-L Kwong
- Institute of Microelectronics, Singapore 117685, Singapore
| | - L Maleki
- OEwaves Inc., Pasadena, California 91107, USA
| | - C W Wong
- Mesoscopic Optics and Quantum Electronics, University of California, Los Angeles, California 90095, USA and Optical Nanostructures Laboratory, Center for Integrated Science and Engineering, Solid-State Science and Engineering, and Mechanical Engineering, Columbia University, New York, New York 10027, USA
| |
Collapse
|
248
|
Abstract
SUMMARY The present meta-analysis shows that a nonlinear association between alcohol consumption and the risk of hip fracture was observed. Light alcohol consumption was inversely significantly associated with hip fracture risk, whereas heavy alcohol consumption was associated with an elevated hip fracture risk. INTRODUCTION Previous studies examining the association between alcohol consumption and the risk of hip fracture have reported conflicting findings. Therefore, we conducted a meta-analysis of prospective cohort studies to assess the association between alcohol consumption and the risk of hip fracture. METHODS PubMed and EMBASE were searched for prospective cohort studies on the relationship between alcohol consumption and the risk of hip fractures. Relative risks (RR) with 95% confidence intervals (CI) were derived using random-effects models throughout the whole analysis. RESULTS Eighteen prospective cohort studies were included with 3,730,424 participants and 26,168 hip fracture cases. Compared with non-drinkers, the pooled RR of hip fractures for alcohol consumption was 1.03 (95% CI, 0.91-1.15), with high heterogeneity between studies (P<0.001, I2=72.6%). A nonlinear relationship between alcohol consumption and the risk of hip fracture was identified (P nonlinearity=0.003). Compared with non-drinkers, the pooled RRs of hip fractures were 0.88 (95% CI, 0.83-0.89) for light alcohol consumption (0.01-12.5 g/day), 1.00 (95% CI, 0.85-1.14) for moderate alcohol consumption (12.6-49.9 g/day), and 1.71 (95% CI, 1.41-2.01) for heavy alcohol consumption (≥50 g/day). CONCLUSIONS There was no evidence of publication bias. In conclusion, a nonlinear association between alcohol consumption and the risk of hip fracture was observed in this meta-analysis. Further, light alcohol consumption was inversely significantly associated with hip fracture risk, whereas heavy alcohol consumption was associated with an elevated hip fracture risk.
Collapse
Affiliation(s)
- X Zhang
- Department of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, China
| | | | | | | |
Collapse
|
249
|
Ou G, Liu Y, Tang Y, You X, Zeng Y, Xiao J, Chen L, Yu M, Wang M, Zhu C. In vitro subminimum inhibitory concentrations of macrolide antibiotics induce macrolide resistance in Mycoplasma pneumoniae. Hippokratia 2015; 19:57-62. [PMID: 26435649 PMCID: PMC4574589] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
AIM This study aims to investigate the inducing effect of subminimum inhibitory concentrations of macrolide antibiotics on Mycoplasma pneumoniae (M. pneumoniae) resistance to drugs. MATERIALS AND METHODS One M. pneumoniae reference strain M129 (ATCC 29342) and 104 clinical isolates were incubated at 37C for 6-8 days. Genomic DNA of M. pneumoniae was extracted using TIANamp Bacteria DNA kit and amplified by polymerase chain reaction (PCR). RESULTS Ten sensitive isolates obtained from 104 M. pneumoniae clinical isolates were induced by subminimum inhibitory concentrations of macrolide antibiotics. Among them, three were found to possess mutations in L4 and L22 ribosomal proteins. Two cases carried simultaneously the C162A and A430G mutations of L4 and the T279C mutation of L22. In addition, one case had only the A209T mutation of L4. CONCLUSIONS Repeated in vitro exposure to subminimum inhibitory concentrations of macrolide antibiotics could induce selective mutations in ribosomal genes of M. pneumoniae clinical isolates that cause resistance to macrolide antibiotics. Hippokratia 2015, 19 (1): 57-62.
Collapse
Affiliation(s)
- G Ou
- Institution of Pathogenic Biology, Medical College, University of South China, Hunan Provincial Key, Laboratory for Special Pathogens Prevention and Control, Hengyang City, Hunan Province, P.R. China
| | - Y Liu
- Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, P.R. China
| | - Y Tang
- Shaoyang Medical College, Shaoyang City, Hunan Province, P.R. China
| | - X You
- Institution of Pathogenic Biology, Medical College, University of South China, Hunan Provincial Key, Laboratory for Special Pathogens Prevention and Control, Hengyang City, Hunan Province, P.R. China
| | - Y Zeng
- Institution of Pathogenic Biology, Medical College, University of South China, Hunan Provincial Key, Laboratory for Special Pathogens Prevention and Control, Hengyang City, Hunan Province, P.R. China
| | - J Xiao
- Institution of Pathogenic Biology, Medical College, University of South China, Hunan Provincial Key, Laboratory for Special Pathogens Prevention and Control, Hengyang City, Hunan Province, P.R. China
| | - L Chen
- Institution of Pathogenic Biology, Medical College, University of South China, Hunan Provincial Key, Laboratory for Special Pathogens Prevention and Control, Hengyang City, Hunan Province, P.R. China
| | - M Yu
- Institution of Pathogenic Biology, Medical College, University of South China, Hunan Provincial Key, Laboratory for Special Pathogens Prevention and Control, Hengyang City, Hunan Province, P.R. China
| | - M Wang
- Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, P.R. China
| | - C Zhu
- Institution of Pathogenic Biology, Medical College, University of South China, Hunan Provincial Key, Laboratory for Special Pathogens Prevention and Control, Hengyang City, Hunan Province, P.R. China
| |
Collapse
|
250
|
Yin Y, Sun Y, Yu M, Liu X, Yang B, Liu D, Liu S, Cao W, Ashfold MNR. Reagent concentration dependent variations in the stability and photoluminescence of silica-coated ZnO nanorods. Inorg Chem Front 2015. [DOI: 10.1039/c4qi00154k] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
ZnO nanorods produced hydrothermally, using different precursor concentrations, show strikingly different morphologies and photoluminescence properties after encapsulation in silica. These differences are traced to differences in the nanorod growth chemistry.
Collapse
Affiliation(s)
- Y. Yin
- Condensed Matter Science and Technology Institute
- School of Science
- Harbin Institute of Technology
- Harbin 150080
- China
| | - Y. Sun
- Condensed Matter Science and Technology Institute
- School of Science
- Harbin Institute of Technology
- Harbin 150080
- China
| | - M. Yu
- State Key Laboratory of Urban Water Resource and Environment
- School of Chemical Engineering and Technology
- Harbin Institute of Technology
- Harbin 150001
- China
| | - X. Liu
- Condensed Matter Science and Technology Institute
- School of Science
- Harbin Institute of Technology
- Harbin 150080
- China
| | - B. Yang
- Condensed Matter Science and Technology Institute
- School of Science
- Harbin Institute of Technology
- Harbin 150080
- China
| | - D. Liu
- Key Laboratory of Microsystems and Microstructures Manufacturing
- Harbin Institute of Technology
- Harbin 150080
- China
| | - S. Liu
- Key Laboratory of Microsystems and Microstructures Manufacturing
- Harbin Institute of Technology
- Harbin 150080
- China
| | - W. Cao
- Condensed Matter Science and Technology Institute
- School of Science
- Harbin Institute of Technology
- Harbin 150080
- China
| | | |
Collapse
|